Three Transporters Mediate Uptake of Glycine Betaine and Carnitine

合集下载

生物药剂学与药代动力学:第五章 药物排泄

生物药剂学与药代动力学:第五章  药物排泄
人体每天的尿量1.5L
重吸收功能:(tubular reabsorption) 近曲小管在管腔侧具有刷状缘结构,有利于吸收。 主动、被动 99%水,葡萄糖,氨基酸,Na+等
排泌功能:(tubular secretion) 物质由血管侧通过上皮细胞侧底膜摄入细胞,再从细胞内 通过刷状缘膜向管腔侧流出的过程。
各种转运蛋白
药物血浆蛋白结合率影响药物肾小球滤过率,对肾小管分泌影响较小
SLC family (SLC载体家族) ABC family(ABC载体家族)
SLC family (SLC载体家族)
The solute carrier (SLC) group of membrane transport proteins include over 400 members organized into 52 families.
ABC family(ABC载体家族) ATP-binding cassette transporters
ABC transporters are members of a transport system superfamily utilizing the energy of ATP binding and hydrolysis to transport various substrates across cellular membranes.
Solutes that are transported by the various SLC group members are extraordinarily diverse and include both charged and uncharged organic molecules as well as inorganic ions and the gas ammonia.

选择性必修第三册 Unit 5 Learning from nature(教师版)

 选择性必修第三册 Unit 5   Learning from nature(教师版)

Ⅰ.阅读单词——会意1.lotus n.莲花,荷花2.termite n.白蚁3.mound n.土堆,土丘4.algae n.藻类(植物)5.pine cone松果,松球6.tile n.瓦片7.mimic v.模仿8.waterfront n.滨水地区9.promenade n.滨海步行道10.plumbing n.管道系统11.biomimicry n.仿生学12.dioxide n.二氧化物13.convert v.使转变;使转换14.frontier n.(学科的)知识前沿15.pond n.池塘16.bat n.蝙蝠17.echo-location n.回声定位18.radar n.雷达19.swimsuit n.游泳衣20.dragonfly n.蜻蜓21.drone n.无人驾驶飞机22.spider n.蜘蛛23.superficially ad v.表面(上)地24.cottage n.乡村小屋25.deliberately ad v.不慌不忙地,从容不迫地26.lane n.(乡间的)小路27.atop prep.在……顶上28.mulberry n.桑葚;桑树29.fulfilment n.满足(感)Ⅱ.重点单词——记形1.superb adj.极好的,出色的2.sow v.播(种)3.physician n.医生4.bow v.鞠躬5.rural adj.农村的,乡村的6.decent adj.可接受的,相当好的7.domestic adj.驯养的;家养的8.reluctant adj.不情愿的;勉强的9.resign v.使自己顺从于(做)某事;安于10.botanical adj.植物(学)的11.ease n.舒适,悠闲12.attain v.得到,获得Ⅲ.拓展单词——悉变1.architect n.建筑师→architecture n.建筑风格,建筑设计2.wisdom n.智慧→wise adj.有智慧的,高明的→unwise adj.不明智的→wisely ad v.明智地3.employ v.使用,运用→employer n.老板,雇主→employee n.员工→employment n.雇用;工作;就业4.withdraw v.退出→withdrawal n.收回;撤退5.depressive adj.抑郁的→depress v.使抑郁→depressed adj.沮丧的→depression n.抑郁症;沮丧;萧条期6.depart v.离开→departure n.离开7.purity n.纯洁;洁净→pure adj.纯洁的,纯净的→purify v.使纯净,净化8.reject v.拒绝接受→rejection n.拒绝9.evaluate v.评估,评价→evaluation n.评估1.persistence /pə's I stəns/n.坚持;锲而不舍→persistent /pə's I stənt/adj.执着的;持续的→persist /pə's I st/v i.& v t.坚持;执意2.take the plunge(尤指思考后的)果断行事;毅然决定3.conclusively /kən'kluːs I vli/ad v.不容置疑地→conclusive /kən'kluːs I v/adj.结论性的;不容置疑的4.bid /b I d/v t.(bid,bid)向(某人)问候(或道别等);出价;投标farewell /ˌfeə'wel/n.告别;辞行bid somebody farewell向某人道别5.feasibility /ˌfiːzə'b I ləti/n.可行性6.credibility /ˌkredə'b I ləti/n.可信性;可靠性7.reinforce /ˌriːI n'fɔːs/v t.加强;加深;加固8.execute /'eks I kjuːt/v t.执行;实施;处决→execution /ˌeks I'kjuːʃn/n.执行;实施;处决9.counsel /'kaʊnsl/n.劝告;忠告;建议v t.提供专业咨询;建议;劝告10.give forth详述;发表(著作、意见等);发出(香味、声音等)Ⅳ.背核心短语1.take...for granted认为……理所当然2.seek solutions to寻求解决办法3.take inspiration from从……中获取灵感4.at ease with不拘束,放松5.convert...into (使)……转变为6.respond to回应,响应7.in return for 作为对……的回报8.draw...from从……中得到……9.be opposed to反对10.withdraw from从……撤出/退出11.in other words换句话说12.resign oneself to听任/顺从/只好接受某事Ⅴ.悟经典句式1.The building was designed to show the connection between nature and the modern city environment in which it sits.(“介词+关系代词”引导定语从句)这座建筑旨在展示自然和它所处的现代城市环境之间的联系。

微生物菌肥中三类菌株的分离_纯化与部分性质鉴定_郭立忠

微生物菌肥中三类菌株的分离_纯化与部分性质鉴定_郭立忠

文章编号:1001-3717(2002)04-0248-03微生物菌肥中三类菌株的分离、纯化与部分性质鉴定Ξ郭立忠1,毕建水2,祝丕业2,李建彬2,李金堂1(1.莱阳农学院植保系,山东莱阳265200;2.莱阳市农业局)摘要:美国进口的奥卡尼克微生物菌肥菌种中含有多种菌株,经本试验证明,其中最主要的菌株有3种:固氮菌、解钾菌、解磷菌,其比例大约为32∶3∶1。

关键词:菌肥;固氮菌;解磷菌;解钾菌中图分类号:S646.1+1 文献标识码:AThe Three Strains’s Saparation、Pured and Part Q ualitiesAppraisal of the Biology B acteria ManureGUO Li-zhong,B I Jian-shui,ZHU Pi-ye,L I Jian-bin,L I Jin-tang(Dept.of Protection,LAC,Laiyang265200,China)Absteract:The biology bacteria manure that comes from American contains many strains.It is proved through the experiment that there are three main strains in it:azotobacteria;potassium bacteria;phosphorus bacteria, proportion is32∶3∶1。

K ey w ords:bacteria manure;azotobacteria;phosphorus bacteria;potassium bacteria 近年来,由于长期使用化肥造成了土壤板结、地力下降、生态破坏、环境污染和农产品质量下降。

微生物菌肥的开发、推广应用受到了农业科技界的高度重视。

微生物菌肥作为一种新的农业技术措施,在发展高产、优质、高效农业中的作用正逐渐被人们所认识。

细胞生物学双语

细胞生物学双语

1.Three classes of lipid found in Biomembranes are Prophoglycerides , Sphingolipids , Cholesterol .生物膜上发现的三种脂质是:甘油磷脂,鞘脂,胆固醇。

2. Proteins interact with membranes in three different ways, there are Integral membrane proteins , Lipid-anchored membrane proteins , Peripheral membrane proteins .蛋白质以跨膜蛋白,脂锚定蛋白,外周膜蛋白这三种不同的方式与膜相互作用。

1.Channel proteins transport water or specific types of ions and hydrophilic small molecules down their concentration or electric potential gradients.通道蛋白运输水、特殊离子以及小分子亲水物质时顺着它们的浓度和电势梯度。

2.Gated channels include Ligand-gated channels and Voltage-gated channels. 门控通道包括配体门通道和电位门通道。

3.Three types of transporters have been identified.They are Uniporters,Symporters,Antiporters. 目前三种转运体被认定,它们分别是单溶质转运体,协同转运体,反向转运体。

(体=蛋白)4.Uniporters transport a single type of molecule down its concentration gradient via facilitated diffusion. Contransporters use the energy stored in the electrochemical gradient of Na+ or H+ ions to power the uphill movement of another substance,which may be a small organic molecule or a different ion.单溶质转运体转运是通过易化扩散顺浓度梯度运送单分子物质的过程,协同转运蛋白使用储蓄在Na+或者H+电化学梯度的能量为动力来向上运输(逆浓度运输)其他物质的过程,比如一份小分子有机物或者一个其他的离子。

输尿管狭窄常见的治疗方法

输尿管狭窄常见的治疗方法

- 180 -*基金项目:宜昌市2021医疗卫生项目(A21-2-032)①三峡大学附属第二人民医院(宜昌市第二人民医院) 湖北 宜昌 443000通信作者:杜丹输尿管狭窄常见的治疗方法*赵仲寅① 杜丹① 胡忠贵① 张志① 贺子秋① 李新宇① 【摘要】 输尿管狭窄可由先天性或继发性原因引起,包括开放或内窥镜手术、结石、创伤等,其中医源性损伤是引起输尿管狭窄的主要原因,可能导致诸多后遗症如上尿路扩张和肾脏区域疼痛等。

若未得到有效医治最后可致肾积水、泌尿系感染、慢性肾功能不全,甚至肾功能衰竭。

输尿管狭窄的治疗对泌尿科医生来说是一个复杂的挑战,可以采用输尿管支架置入、球囊扩张等进行治疗,另外,除了上述治疗外,也可以采用输尿管端端吻合术、膀胱瓣输尿管成形术等进行狭窄修复,同时利用自体补片进行输尿管重建近年来也越来越多,并且随着腹腔镜技术的进步,泌尿外科医生可以联合腹腔镜进行输尿管修复重建,具有早日康复、减少失血和疼痛的优势。

本文章就目前临床上常用的手术方式做一综述。

【关键词】 输尿管狭窄 输尿管支架 球囊扩张 口腔黏膜 doi:10.14033/ki.cfmr.2024.05.043 文献标识码 A 文章编号 1674-6805(2024)05-0180-05 Common Treatment Method for Ureteral Stricture/ZHAO Zhongyin, DU Dan, HU Zhonggui, ZHANG Zhi, HE Ziqiu, LI Xinyu. //Chinese and Foreign Medical Research, 2024, 22(5): 180-184 [Abstract] Ureteral stenosis can be caused by congenital or secondary causes, including open or endoscopic surgery, calculi, trauma etc. Iatrogenic injury is the main cause of ureteral stenosis, which may lead to many sequelae such as upper urinary tract dilation and kidney pain. If not effectively treated, it can eventually lead to hydronephrosis, urinary tract infection, chronic renal insufficiency, and even renal failure. The treatment of ureteral stricture is a complex challenge for urologists, which can be treated by ureteral stent implantation, balloon dilation etc. In addition, except for the above treatment, ureteral stenosis can also be repaired by end-to-end ureteral anastomosis, bladder flap ureteroplasty etc. Meanwhile, ureteral reconstruction using self patch has become increasingly popular in recent years. And with the advancement of laparoscopic technology, urological surgeons can combine laparoscopic ureteral repair and reconstruction, with the advantages of early recovery, reducing blood loss and pain. This article reviews the common surgical methods in clinic. [Key words] Ureter sterosis Ureteral stent Balloon dilatation Buccal mucosa First-author's address: The Second Affiliated People's Hospital of China Three Gorges University, Yichang 443000, China 输尿管狭窄的修复对泌尿科医生来说是一个复杂的挑战。

细胞生物学(双语)第三章

细胞生物学(双语)第三章

Passive diffusion (simple diffusion)
• Conception: 疏水的小分子或小的不带电荷的极 性分子在以简单扩散的方式跨膜转运中, 性分子在以简单扩散的方式跨膜转运中,不需 要细胞提供能量,也没有膜蛋白的协助, 要细胞提供能量,也没有膜蛋白的协助,称为 简单扩散
Two classes of membrane transport proteins
Carrier proteins are responsible for both the passive and the active transport. Channel proteins are only responsible for passive transport.
Three distinct character
• High transport speed (106 ions/s)(转运速率高) (转运速率高) • Specific selectivity(选择性) (选择性) • Gated channel(门控) (门控)
Aquaporin 水孔蛋白
A class of integral membrane protein Channel of molecular water Regulated by phosphorylation plasmolysis
Diffusion of small molecules across phospholipid bilayers
C. The energetics of solute movement:
Diffusion is the spontaneous movement of material from a region of high concentration to a region of low concentration. The free-energy change during diffusion of nonelectrolytes depends on the concentration gradient. The free-energy change during diffusion of electrolytes depends on the electrochemical gradient.

核磁常见溶剂峰

核磁常见溶剂峰

NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities Hugo E.Gottlieb,*Vadim Kotlyar,andAbraham Nudelman*Department of Chemistry,Bar-Ilan University,Ramat-Gan52900,IsraelReceived June27,1997In the course of the routine use of NMR as an aid for organic chemistry,a day-to-day problem is the identifica-tion of signals deriving from common contaminants (water,solvents,stabilizers,oils)in less-than-analyti-cally-pure samples.This data may be available in the literature,but the time involved in searching for it may be considerable.Another issue is the concentration dependence of chemical shifts(especially1H);results obtained two or three decades ago usually refer to much more concentrated samples,and run at lower magnetic fields,than today’s practice.We therefore decided to collect1H and13C chemical shifts of what are,in our experience,the most popular “extra peaks”in a variety of commonly used NMR solvents,in the hope that this will be of assistance to the practicing chemist.Experimental SectionNMR spectra were taken in a Bruker DPX-300instrument (300.1and75.5MHz for1H and13C,respectively).Unless otherwise indicated,all were run at room temperature(24(1°C).For the experiments in the last section of this paper,probe temperatures were measured with a calibrated Eurotherm840/T digital thermometer,connected to a thermocouple which was introduced into an NMR tube filled with mineral oil to ap-proximately the same level as a typical sample.At each temperature,the D2O samples were left to equilibrate for at least 10min before the data were collected.In order to avoid having to obtain hundreds of spectra,we prepared seven stock solutions containing approximately equal amounts of several of our entries,chosen in such a way as to prevent intermolecular interactions and possible ambiguities in assignment.Solution1:acetone,tert-butyl methyl ether,di-methylformamide,ethanol,toluene.Solution2:benzene,di-methyl sulfoxide,ethyl acetate,methanol.Solution3:acetic acid,chloroform,diethyl ether,2-propanol,tetrahydrofuran. Solution4:acetonitrile,dichloromethane,dioxane,n-hexane, HMPA.Solution5:1,2-dichloroethane,ethyl methyl ketone, n-pentane,pyridine.Solution6:tert-butyl alcohol,BHT,cyclo-hexane,1,2-dimethoxyethane,nitromethane,silicone grease, triethylamine.Solution7:diglyme,dimethylacetamide,ethyl-ene glycol,“grease”(engine oil).For D2O.Solution1:acetone, tert-butyl methyl ether,dimethylformamide,ethanol,2-propanol. Solution2:dimethyl sulfoxide,ethyl acetate,ethylene glycol, methanol.Solution3:acetonitrile,diglyme,dioxane,HMPA, pyridine.Solution4:1,2-dimethoxyethane,dimethylacetamide, ethyl methyl ketone,triethylamine.Solution5:acetic acid,tert-butyl alcohol,diethyl ether,tetrahydrofuran.In D2O and CD3OD nitromethane was run separately,as the protons exchanged with deuterium in presence of triethylamine.ResultsProton Spectra(Table1).A sample of0.6mL of the solvent,containing1µL of TMS,1was first run on its own.From this spectrum we determined the chemical shifts of the solvent residual peak2and the water peak. It should be noted that the latter is quite temperature-dependent(vide infra).Also,any potential hydrogen-bond acceptor will tend to shift the water signal down-field;this is particularly true for nonpolar solvents.In contrast,in e.g.DMSO the water is already strongly hydrogen-bonded to the solvent,and solutes have only a negligible effect on its chemical shift.This is also true for D2O;the chemical shift of the residual HDO is very temperature-dependent(vide infra)but,maybe counter-intuitively,remarkably solute(and pH)independent. We then added3µL of one of our stock solutions to the NMR tube.The chemical shifts were read and are presented in Table 1.Except where indicated,the coupling constants,and therefore the peak shapes,are essentially solvent-independent and are presented only once.For D2O as a solvent,the accepted reference peak(δ)0)is the methyl signal of the sodium salt of3-(trimeth-ylsilyl)propanesulfonic acid;one crystal of this was added to each NMR tube.This material has several disadvan-tages,however:it is not volatile,so it cannot be readily eliminated if the sample has to be recovered.In addition, unless one purchases it in the relatively expensive deuterated form,it adds three more signals to the spectrum(methylenes1,2,and3appear at2.91,1.76, and0.63ppm,respectively).We suggest that the re-sidual HDO peak be used as a secondary reference;we find that if the effects of temperature are taken into account(vide infra),this is very reproducible.For D2O, we used a different set of stock solutions,since many of the less polar substrates are not significantly water-soluble(see Table1).We also ran sodium acetate and sodium formate(chemical shifts: 1.90and8.44ppm, respectively).Carbon Spectra(Table2).To each tube,50µL of the stock solution and3µL of TMS1were added.The solvent chemical shifts3were obtained from the spectra containing the solutes,and the ranges of chemical shifts(1)For recommendations on the publication of NMR data,see: IUPAC Commission on Molecular Structure and Spectroscopy.Pure Appl.Chem.1972,29,627;1976,45,217.(2)I.e.,the signal of the proton for the isotopomer with one less deuterium than the perdeuterated material,e.g.,C H Cl3in CDCl3or C6D5H in C6D6.Except for CHCl3,the splitting due to J HD is typically observed(to a good approximation,it is1/6.5of the value of the corresponding J HH).For CHD2groups(deuterated acetone,DMSO, acetonitrile),this signal is a1:2:3:2:1quintet with a splitting of ca.2 Hz.(3)In contrast to what was said in note2,in the13C spectra the solvent signal is due to the perdeuterated isotopomer,and the one-bond couplings to deuterium are always observable(ca.20-30Hz). Figure1.Chemical shift of H DO as a function of tempera-ture..Chem.1997,62,7512-7515S0022-3263(97)01176-6CCC:$14.00©1997American Chemical Societyshow their degree of variability.Occasionally,in order to distinguish between peaks whose assignment was ambiguous,a further1-2µL of a specific substrate were added and the spectra run again.Table1.1H NMR Dataproton mult CDCl3(CD3)2CO(CD3)2SO C6D6CD3CN CD3OD D2O solvent residual peak7.26 2.05 2.507.16 1.94 3.31 4.79 H2O s 1.56 2.84a 3.33a0.40 2.13 4.87acetic acid CH3s 2.10 1.96 1.91 1.55 1.96 1.99 2.08 acetone CH3s 2.17 2.09 2.09 1.55 2.08 2.15 2.22 acetonitrile CH3s 2.10 2.05 2.07 1.55 1.96 2.03 2.06 benzene CH s7.367.367.377.157.377.33tert-butyl alcohol CH3s 1.28 1.18 1.11 1.05 1.16 1.40 1.24 OH c s 4.19 1.55 2.18tert-butyl methyl ether CCH3s 1.19 1.13 1.11 1.07 1.14 1.15 1.21 OCH3s 3.22 3.13 3.08 3.04 3.13 3.20 3.22 BHT b ArH s 6.98 6.96 6.877.05 6.97 6.92OH c s 5.01 6.65 4.79 5.20ArCH3s 2.27 2.22 2.18 2.24 2.22 2.21ArC(CH3)3s 1.43 1.41 1.36 1.38 1.39 1.40chloroform CH s7.268.028.32 6.157.587.90 cyclohexane CH2s 1.43 1.43 1.40 1.40 1.44 1.451,2-dichloroethane CH2s 3.73 3.87 3.90 2.90 3.81 3.78 dichloromethane CH2s 5.30 5.63 5.76 4.27 5.44 5.49diethyl ether CH3t,7 1.21 1.11 1.09 1.11 1.12 1.18 1.17 CH2q,7 3.48 3.41 3.38 3.26 3.42 3.49 3.56 diglyme CH2m 3.65 3.56 3.51 3.46 3.53 3.61 3.67 CH2m 3.57 3.47 3.38 3.34 3.45 3.58 3.61OCH3s 3.39 3.28 3.24 3.11 3.29 3.35 3.37 1,2-dimethoxyethane CH3s 3.40 3.28 3.24 3.12 3.28 3.35 3.37 CH2s 3.55 3.46 3.43 3.33 3.45 3.52 3.60 dimethylacetamide CH3CO s 2.09 1.97 1.96 1.60 1.97 2.07 2.08 NCH3s 3.02 3.00 2.94 2.57 2.96 3.31 3.06NCH3s 2.94 2.83 2.78 2.05 2.83 2.92 2.90 dimethylformamide CH s8.027.967.957.637.927.977.92 CH3s 2.96 2.94 2.89 2.36 2.89 2.99 3.01CH3s 2.88 2.78 2.73 1.86 2.77 2.86 2.85 dimethyl sulfoxide CH3s 2.62 2.52 2.54 1.68 2.50 2.65 2.71 dioxane CH2s 3.71 3.59 3.57 3.35 3.60 3.66 3.75 ethanol CH3t,7 1.25 1.12 1.060.96 1.12 1.19 1.17 CH2q,7d 3.72 3.57 3.44 3.34 3.54 3.60 3.65OH s c,d 1.32 3.39 4.63 2.47ethyl acetate CH3CO s 2.05 1.97 1.99 1.65 1.97 2.01 2.07C H2CH3q,7 4.12 4.05 4.03 3.89 4.06 4.09 4.14CH2C H3t,7 1.26 1.20 1.170.92 1.20 1.24 1.24 ethyl methyl ketone CH3CO s 2.14 2.07 2.07 1.58 2.06 2.12 2.19C H2CH3q,7 2.46 2.45 2.43 1.81 2.43 2.50 3.18CH2C H3t,7 1.060.960.910.850.96 1.01 1.26 ethylene glycol CH s e 3.76 3.28 3.34 3.41 3.51 3.59 3.65“grease”f CH3m0.860.870.920.860.88CH2br s 1.26 1.29 1.36 1.27 1.29n-hexane CH3t0.880.880.860.890.890.90CH2m 1.26 1.28 1.25 1.24 1.28 1.29HMPA g CH3d,9.5 2.65 2.59 2.53 2.40 2.57 2.64 2.61 methanol CH3s h 3.49 3.31 3.16 3.07 3.28 3.34 3.34 OH s c,h 1.09 3.12 4.01 2.16nitromethane CH3s 4.33 4.43 4.42 2.94 4.31 4.34 4.40 n-pentane CH3t,70.880.880.860.870.890.90CH2m 1.27 1.27 1.27 1.23 1.29 1.292-propanol CH3d,6 1.22 1.10 1.040.95 1.09 1.50 1.17 CH sep,6 4.04 3.90 3.78 3.67 3.87 3.92 4.02 pyridine CH(2)m8.628.588.588.538.578.538.52 CH(3)m7.297.357.39 6.667.337.447.45CH(4)m7.687.767.79 6.987.737.857.87 silicone grease i CH3s0.070.130.290.080.10 tetrahydrofuran CH2m 1.85 1.79 1.76 1.40 1.80 1.87 1.88 CH2O m 3.76 3.63 3.60 3.57 3.64 3.71 3.74 toluene CH3s 2.36 2.32 2.30 2.11 2.33 2.32CH(o/p)m7.177.1-7.27.187.027.1-7.37.16CH(m)m7.257.1-7.27.257.137.1-7.37.16 triethylamine CH3t,7 1.030.960.930.960.96 1.050.99 CH2q,7 2.53 2.45 2.43 2.40 2.45 2.58 2.57a In these solvents the intermolecular rate of exchange is slow enough that a peak due to HDO is usually also observed;it appears at2.81and3.30ppm in acetone and DMSO,respectively.In the former solvent,it is often seen as a1:1:1triplet,with2J H,D)1Hz. b2,6-Dimethyl-4-tert-butylphenol.c The signals from exchangeable protons were not always identified.d In some cases(see note a),the coupling interaction between the CH2and the OH protons may be observed(J)5Hz).e In CD3CN,the OH proton was seen as a multiplet atδ2.69,and extra coupling was also apparent on the methylene peak.f Long-chain,linear aliphatic hydrocarbons.Their solubility in DMSO was too low to give visible peaks.g Hexamethylphosphoramide.h In some cases(see notes a,d),the coupling interaction between the CH3and the OH protons may be observed(J)5.5Hz).i Poly(dimethylsiloxane).Its solubility in DMSO was too low to give visible peaks.Notes .Chem.,Vol.62,No.21,19977513.Chem.,Vol.62,No.21,1997NotesTable2.13C NMR Data aCDCl3(CD3)2CO(CD3)2SO C6D6CD3CN CD3OD D2O solvent signals77.16(0.0629.84(0.0139.52(0.06128.06(0.02 1.32(0.0249.00(0.01206.26(0.13118.26(0.02acetic acid CO175.99172.31171.93175.82173.21175.11177.21 CH320.8120.5120.9520.3720.7320.5621.03 acetone CO207.07205.87206.31204.43207.43209.67215.94 CH330.9230.6030.5630.1430.9130.6730.89 acetonitrile CN116.43117.60117.91116.02118.26118.06119.68 CH3 1.89 1.12 1.030.20 1.790.85 1.47 benzene CH128.37129.15128.30128.62129.32129.34tert-butyl alcohol C69.1568.1366.8868.1968.7469.4070.36 CH331.2530.7230.3830.4730.6830.9130.29 tert-butyl methyl ether OCH349.4549.3548.7049.1949.5249.6649.37 C72.8772.8172.0472.4073.1774.3275.62C C H326.9927.2426.7927.0927.2827.2226.60 BHT C(1)151.55152.51151.47152.05152.42152.85C(2)135.87138.19139.12136.08138.13139.09CH(3)125.55129.05127.97128.52129.61129.49C(4)128.27126.03124.85125.83126.38126.11CH3Ar21.2021.3120.9721.4021.2321.38C H3C30.3331.6131.2531.3431.5031.15C34.2535.0034.3334.3535.0535.36chloroform CH77.3679.1979.1677.7979.1779.44cyclohexane CH226.9427.5126.3327.2327.6327.961,2-dichloroethane CH243.5045.2545.0243.5945.5445.11 dichloromethane CH253.5254.9554.8453.4655.3254.78diethyl ether CH315.2015.7815.1215.4615.6315.4614.77 CH265.9166.1262.0565.9466.3266.8866.42 diglyme CH359.0158.7757.9858.6658.9059.0658.67 CH270.5171.0369.5470.8770.9971.3370.05CH271.9072.6371.2572.3572.6372.9271.63 1,2-dimethoxyethane CH359.0858.4558.0158.6858.8959.0658.67 CH271.8472.4717.0772.2172.4772.7271.49 dimethylacetamide CH321.5321.5121.2921.1621.7621.3221.09 CO171.07170.61169.54169.95171.31173.32174.57NCH335.2834.8937.3834.6735.1735.5035.03NCH338.1337.9234.4237.0338.2638.4338.76 dimethylformamide CH162.62162.79162.29162.13163.31164.73165.53 CH336.5036.1535.7335.2536.5736.8937.54CH331.4531.0330.7330.7231.3231.6132.03 dimethyl sulfoxide CH340.7641.2340.4540.0341.3140.4539.39 dioxane CH267.1467.6066.3667.1667.7268.1167.19 ethanol CH318.4118.8918.5118.7218.8018.4017.47 CH258.2857.7256.0757.8657.9658.2658.05 ethyl acetate C H3CO21.0420.8320.6820.5621.1620.8821.15 CO171.36170.96170.31170.44171.68172.89175.26CH260.4960.5659.7460.2160.9861.5062.32CH314.1914.5014.4014.1914.5414.4913.92 ethyl methyl ketone C H3CO29.4929.3029.2628.5629.6029.3929.49 CO209.56208.30208.72206.55209.88212.16218.43C H2CH336.8936.7535.8336.3637.0937.3437.27CH2C H37.868.037.617.918.148.097.87 ethylene glycol CH263.7964.2662.7664.3464.2264.3063.17“grease”CH229.7630.7329.2030.2130.8631.29n-hexane CH314.1414.3413.8814.3214.4314.45CH2(2)22.7023.2822.0523.0423.4023.68CH2(3)31.6432.3030.9531.9632.3632.73HMPA b CH336.8737.0436.4236.8837.1037.0036.46 methanol CH350.4149.7748.5949.9749.9049.8649.50c nitromethane CH362.5063.2163.2861.1663.6663.0863.22 n-pentane CH314.0814.2913.2814.2514.3714.39CH2(2)22.3822.9821.7022.7223.0823.38CH2(3)34.1634.8333.4834.4534.8935.302-propanol CH325.1425.6725.4325.1825.5525.2724.38 CH64.5063.8564.9264.2364.3064.7164.88 pyridine CH(2)149.90150.67149.58150.27150.76150.07149.18 CH(3)123.75124.57123.84123.58127.76125.53125.12CH(4)135.96136.56136.05135.28136.89138.35138.27 silicone grease CH3 1.04 1.40 1.38 2.10 tetrahydrofuran CH225.6226.1525.1425.7226.2726.4825.67 CH2O67.9768.0767.0367.8068.3368.8368.68 toluene CH321.4621.4620.9921.1021.5021.50C(i)137.89138.48137.35137.91138.90138.85CH(o)129.07129.76128.88129.33129.94129.91CH(m)128.26129.03128.18128.56129.23129.20CH(p)125.33126.12125.29125.68126.28126.29triethylamine CH311.6112.4911.7412.3512.3811.099.07 CH246.2547.0745.7446.7747.1046.9647.19a See footnotes for Table1.b2J PC)3Hz.c Reference material;see text.For D2O solutions there is no accepted reference for carbon chemical shifts.We suggest the addition of a drop of methanol,and the position of its signal to be defined as49.50ppm;on this basis,the entries in Table2were recorded.The chemical shifts thus obtained are,on the whole,very similar to those for the other solvents. Alternatively,we suggest the use of dioxane when the methanol peak is expected to fall in a crowded area of the spectrum.We also report the chemical shifts of sodium formate(171.67ppm),sodium acetate(182.02and 23.97ppm),sodium carbonate(168.88ppm),sodium bicarbonate(161.08ppm),and sodium3-(trimethylsilyl)-propanesulfonate[54.90,19.66,15.56(methylenes1,2, and3,respectively),and-2.04ppm(methyls)],in D2O. Temperature Dependence of HDO Chemical Shifts.We recorded the1H spectrum of a sample of D2O, containing a crystal of sodium3-(trimethylsilyl)propane-sulfonate as reference,as a function of temperature.The data are shown in Figure1.The solid line connecting the experimental points corresponds to the equation which reproduces the measured values to better than1 ppb.For the0-50o C range,the simplergives values correct to10ppb.For both equations,T is the temperature in°C.Acknowledgment.Generous support for this work by the Minerva Foundation and the Otto Mayerhoff Center for the Study of Drug-Receptor Interactions at Bar-Ilan University is gratefully acknowledged.JO971176Vδ)5.060-0.0122T+(2.11×10-5)T2(1)δ)5.051-0.0111T(2)Notes .Chem.,Vol.62,No.21,19977515。

纹理物体缺陷的视觉检测算法研究--优秀毕业论文

纹理物体缺陷的视觉检测算法研究--优秀毕业论文

摘 要
在竞争激烈的工业自动化生产过程中,机器视觉对产品质量的把关起着举足 轻重的作用,机器视觉在缺陷检测技术方面的应用也逐渐普遍起来。与常规的检 测技术相比,自动化的视觉检测系统更加经济、快捷、高效与 安全。纹理物体在 工业生产中广泛存在,像用于半导体装配和封装底板和发光二极管,现代 化电子 系统中的印制电路板,以及纺织行业中的布匹和织物等都可认为是含有纹理特征 的物体。本论文主要致力于纹理物体的缺陷检测技术研究,为纹理物体的自动化 检测提供高效而可靠的检测算法。 纹理是描述图像内容的重要特征,纹理分析也已经被成功的应用与纹理分割 和纹理分类当中。本研究提出了一种基于纹理分析技术和参考比较方式的缺陷检 测算法。这种算法能容忍物体变形引起的图像配准误差,对纹理的影响也具有鲁 棒性。本算法旨在为检测出的缺陷区域提供丰富而重要的物理意义,如缺陷区域 的大小、形状、亮度对比度及空间分布等。同时,在参考图像可行的情况下,本 算法可用于同质纹理物体和非同质纹理物体的检测,对非纹理物体 的检测也可取 得不错的效果。 在整个检测过程中,我们采用了可调控金字塔的纹理分析和重构技术。与传 统的小波纹理分析技术不同,我们在小波域中加入处理物体变形和纹理影响的容 忍度控制算法,来实现容忍物体变形和对纹理影响鲁棒的目的。最后可调控金字 塔的重构保证了缺陷区域物理意义恢复的准确性。实验阶段,我们检测了一系列 具有实际应用价值的图像。实验结果表明 本文提出的纹理物体缺陷检测算法具有 高效性和易于实现性。 关键字: 缺陷检测;纹理;物体变形;可调控金字塔;重构
Keywords: defect detection, texture, object distortion, steerable pyramid, reconstruction
II

固相支撑液液萃取结合LC-MS

固相支撑液液萃取结合LC-MS

邓龙,周思,黄佳佳,等. 固相支撑液液萃取结合LC-MS/MS 快速测定生乳中32种农药残留[J]. 食品工业科技,2023,44(17):360−366. doi: 10.13386/j.issn1002-0306.2022120075DENG Long, ZHOU Si, HUANG Jiajia, et al. Determination of 32 Kinds of Pesticide Residues in Raw Milk by Supported Liquid Extraction with LC-MS/MS[J]. Science and Technology of Food Industry, 2023, 44(17): 360−366. (in Chinese with English abstract).doi: 10.13386/j.issn1002-0306.2022120075· 分析检测 ·固相支撑液液萃取结合LC-MS/MS 快速测定生乳中32种农药残留邓 龙1,周 思2, *,黄佳佳1,曾上敏1,张静文1(1.广东食品药品职业学院,广东广州 510520;2.广州市疾病预防控制中心,广东广州 510440)摘 要:将固相支撑液液萃取与超高效液相色谱串联质谱法结合,建立生乳中32种农药残留的快速检测方法,为保障生乳食品安全提供技术支持。

样品加入乙腈沉淀蛋白,高速离心分离,上清液用固相支撑液液萃取小柱净化,C 18色谱柱梯度洗脱分离后,经串联质谱电喷雾模式扫描,多反应监测模式检测,以基质匹配校准曲线外标法定量。

结果表明,32种目标物在一定范围内线性关系良好,相关系数大于0.9962,检出限为0.1~2.5 μg/kg ,定量限为0.3~7.5 μg/kg ,平均回收率为69.4%~113.8%,相对标准偏差(n=6)小于8.2%。

该方法简单、快速、可靠,适用于生乳中32种农药残留的测定。

细胞生物学课件英文版-物质跨膜运输

细胞生物学课件英文版-物质跨膜运输
– Superfamilies of ion channels have been discovered by cloning analysis of protein sequences, site directed mutagenesis, and patch-clamping experiments.
The Na+/K+-ATPase pump
The Movement of Substances Across Cell Membranes (14)
• Other Ion Transport Systems
– The Na+/K+ ATPase (sodium-potassium pump)requires K+ outside, Na+ inside, and is inhibited by ouabain.
– The ratio of Na+:K+ pumped is 3:2.
– The ATPase is a P-type pump, in which phosphorylation causes changes in conformation and ion affinity that allow transport against gradients.
– Insulin stimulates glucose uptake by causing the insertion into the cell membrane of vesicles containing preformed glucose transporters.
The Glucose Transporter
The Movement of Substances Across Cell Membranes (6)

必修第三册 Unit 3 The world of science(教师版)

 必修第三册 Unit 3 The world of science(教师版)

Ⅰ.阅读单词——会意1.gunpowder n.火药2.compass n.指南针,罗盘3.virtual adj.虚拟的,模拟的4.battery n.电池5.compute v.计算6.stuff n.东西,物品7.astronomer n.天文学家8.Gregorian calendar 公历,阳历(自1582年起在西方使用的历法) 9.species n.物种10.stream n.小河,小溪11.radium n.镭(一种化学元素)12.lightning n.闪电13.fiction n.虚构的事,想象的事14.metal n.金属15.gravity n.重力,引力Ⅱ.重点单词——记形1.press v.按2.shoot v.射出(光线等),放射3.desire n.渴望,欲望4.passive adj.被动的5.beyond prep.无法……6.instance n.例子,实例7.extraordinary adj.非凡的,出色的8.brilliant adj.聪颖的,才华横溢的9.theory n.学说,理论10.mental adj.精神的;精神健康的11.cure n.药剂;疗法12.draft v.起草,草拟13.experiment n.(科学)实验14.flash n.闪光15.entirely ad v.完全地,彻底地16.account n.记述,描述17.proof n.证明,证据18.procedure n.程序,步骤,手续Ⅲ.拓展单词——悉变1.flexible adj.易弯曲的,柔韧的→flexibly ad v.灵活地;有弹性地→flexibility n.灵活性;弹性;适应性2.capable adj.有能力的→capability n.能力3.significant adj.重要的,影响深远的→significance n.重要性,意义4.injure v.使受伤,弄伤→injury n.伤;损害→injured adj.受伤的5.chemist n.化学家;药剂师;药房→chemistry n.化学→chemical adj.化学的6.biologist n.生物学家→biology n.生理;生物学→biological adj.生物(学)的7.accurate adj.精确的→accurately ad v.精确地→accuracy n.精确度,准确性8.minor adj.小的;次要的→minority n.少数9.origin n.起源,起因→original adj.最初的,原始的n.原作→originally ad v.原来,最初10.declaration n.声明,宣告→declare v.宣布11.attach v.系,绑;贴;附→attached adj.附属于;依恋的→attachment n.附件;连接物;依恋12.conduct v.传导(热、电);指挥;实施→conductor n.导体;指挥;售票员13.scientific adj.科学(上)的→science n.科学;理科→scientist n.科学家1.mobilise (NAmE -ize) /'məʊbəla I z/v t.& v i.组织;鼓动;动员2.neutrality /njuː'træləti/n.中立;中立状态3.invade /I n've I d/v i.& v t.武装入侵;侵略;侵犯4.surrender /sə'rendə(r)/v i.& v t.投降;(被迫)放弃,交出n.投降;屈服;屈从5.fight back还击;抵抗6.assault /ə'sɔːlt/n.攻击;突击;袭击v t.猛烈攻击;袭击;侵犯(尤指构成犯罪)7.swift /sw I ft/adj.迅即发生的;速度快的;敏捷的8.intact /I n'tækt/adj.完好无损;完整9.reinforcement /ˌriːI n'fɔːsmənt/n.[pl.]援军;增援警力[U](感情或思想等的)巩固;加强10.fate /fe I t/n.命中注定的事(尤指坏事);命运Ⅳ.背核心短语1.wearable tech 可穿戴技术2.in addition 除此之外,另外3.never say never 别轻易说决不4.natural selection 自然选择5.field research 实地研究,实地调研6.instead of代替;而不是7.in terms of 按照;谈及;在……方面8.along with连同……一起9.take place 发生;举行10.die from死于;因……而死Ⅴ.悟经典句式1.There have been golden ages of invention throughout history.(there be 句型)纵观历史,我们经历过很多发明创造的黄金时代。

PassiveandActiveTransport被动和主动运输

PassiveandActiveTransport被动和主动运输

Passive and Active Transport1. Thermodynamics oftransport2. Passive-mediatedtransport3. Active transportneuron, membrane potential,ion transportMembranes• Provide barrier function– Extracellular– Organelles• Barrier can be overcome by …transport proteins“ – To mediate transmembrane movements of ions, Na+, K+ – Nutrients, glucose, amino acids etc.– Water (aquaporins)1) Thermodynamics of Transport• A out <-> A in (ressembles a chemical equilibration) • G A - G o‘A = RT ln [A]• ∆G A = G A(in) - G A(out) = RT ln ([A]in/[A]out)• G A: chemical potential of A• G o‘A: chemical potential of standard state of A• If membrane has a potential,i.e., plasma membrane: -100mV (inside negative) then G A is termed the electrochemical potential of ATwo types of transport acrossa membrane:o Nonmediated transport occurs by passive diffusion, i.e., O2, CO2driven by chemical potential gradient, i.e.cannot occur against a concentration gradiento Mediated transport occurs by dedicated transport proteins1. Passive-mediated transport/facilitated diffusion:[high] -> [low]2. Active transport: [low] -> [high]May require energy in form of ATP or in form of amembrane potential2) Passive-mediated transport Substances that are too large or too polar to diffuse across the bilayer must be transported by proteins: carriers, permeases, channels and transportersA) IonophoresB) PorinsC) Ion ChannelsD) AquaporinsE) Transport ProteinsA) IonophoresOrganic molecules of divers types, often of bacterial origin => Increase the permeability of a target membrane for ions, frequently antibiotic, result in collapse of target membrane potential by ion equilibration1. Carrier Ionophore,make ion soluble inmembrane, i.e. valinomycin,104 K+/sec2. Cannel-formingionophores, formtransmembrane channels,gramicidin A, 107 K+/secValinomycino One of the best characterized ionophores, binds K+ ionso Cyclic peptide with D- and L-Aao Discrimination between Na+, K+, Li+ ?K+ (r=1.33Å), Na+ (r=0.95Å)Gramicidin Ao 15 Aa linear peptideo Alternating D- and L-Aa, all hydrophobic o Dimerizes head-to-head to form channelB) Porinso Membrane spanning proteins with β-barrel structure,with central aqueous channel, diameter ~ 7x11Å~600 D, little substrate selectivity, E. coli OmpFo Maltoporin, substrate selectivity for maltodextrins, α(1->4)-linked glucose oligossaccharide degradation products of starch, greasy slideC) Ion Channelso All organisms have channels for Na+, K+, and Cl-o Membrane transport of these ions is important for: o Osmotic balanceo Signal transductiono Membrane potentialo Mammalian cells:extracellular: 150mM Na+, 4mM K+intracellular: 12mM Na+, 140mM K+passive diffusion of K+ ions through opening of K+-channels from cytosol to extracellular spaceK+-channels have high selectivity of K+ over Na+ selectivity 104The K+-channel, KcsAo Streptomyces,Functions as a homotetramer, 158 Aa, 108 ions/sec, Roderick MacKinnono Selectivity filter allows passage of K+ but not Na+The selectivity filter o The ion needs to bedehydrated to pass throughthe most narrow opening ofthe channelo In the dehydration, water isreplaced by hydroxyl groupsfrom the channels aminoacidso These hydroxyls willstabilize K+ but not Na+,because Na+ is much smallerthan K+o Cavity in the middle of thechannel = middle of themembrane Contains waterIon channels are gatedo Channels can be closed and opened upon signal: o Mechanosensitive channels open in response tomembrane deformation: touch, sound, osmoticpressureo Ligand-gated channels open in response toextracellular chemical stimulus: neurotransmission o Signal-gated channel, open for example onintracellular binding of Ca2+o Voltage-gated channel: open in response tomembrane potential change, transmission of nerve impulsesNerve impulses are propagatedby action potentialso Stimulus of neuron results in opening of Na+ channels -> local depolarization, induces nearby voltage-gated K+ to open as well (repolarization)o Spontaneous closure of channels before N+ / K+ equilibrium is reachedo Wave of directional transmission to nearby channels -> propagation of signal along the axon = action potential (~10m/sec), no reduction in amplitude (≠electrical wire), can be repetitive (ms)Time course of an actionpotentialVoltage gated K V channels o Tetramer, S5,S6 ~KcsA, T1 domain in cytosolo Gating by the motion of a protein paddleo S4 helix contains 5 positive charges, spaced by 3Aa = acts as voltage sensorModel for gating of K V channels o Gating by the motion of a protein paddle, S4 helixo Increase in membrane potential, inside becomes less negative -> baddle moves ->pore opensIon channels have two gates o One to open and one tocloseo T1 domain containsinactivation peptidethat blocks poreentrance a few msafter V-dependentpore openingCl - channel differ from cation channels o Present in all cell types. Permit transmembrane movement of chloride ions along concentration gradient: [Cl -] extracellular: 120mM;intracellular 4mMo Homodimer with each 18TMDso Permit rapid rates of water transport across the membrane (kidney, Hg2+), (3 109/sec), Peter Agre (1992); 11 genes in humano AQP1, homotetrameric glycoprotein, 6TMDs, elongated hourglass with central poreo Constriction region, 2.8Å narrow• Only dehydrated water can pass• Only 1 at the time, reorientation of dipol• Selectivity filter similar to KscA• No proton conducting wire allowedo Erythrocyte glucose transporter, GLUT1 o Has glucose binding sites on both sites of membrane (propyl on C1 prevents bdg to outer surface, propyl on C6 prevents bdg on inner site) o Assymetric bdg sites o 12 TMDs forms tetramer o Transport proteins alternate between two conformationsi.e. GLUT1i.e. oxalate transporter oxalate in, formate out, (Na +-K +)-ATPasei.e. Na + glucose symporter Lactose permeaseGap Junctionso Form Cell-Cell connections, Connexins form gap junctionso Cells within a organ are in metabolic and physical contact with neighboring cells through gap junctions, 16-20Å pore, 1000 Do Two apposed plasma membrane complexeso Closed by Ca2+Inactivation, heat, protease...mediated3) Active Transport Transport against a concentration gradient, endergonic process, frequently requires ATP or other energy sources (i.e., trans-membrane potential = secondary activetransport !)Example: Glucose concentration in blood is around 5mM Glut1 cannot increase the intracellularglucose concentration in the erythrocyte abovethis 5mM this would require an energy consumingtransporterClasses of ATPasesAll consume intracellular ATP for the transport process:1. P-type ATPases undergo internal phosporhylation duringtransport cycle, i.e. Na+, K+, Ca2+2. F-type ATPase, proton transportes in mitochondria,synthesize ATP3. V-type ATPase, acidify a cellular compartment: vacuole,lysosome4. A-type ATPase transport anions across membranes5. ABC transporters, ATP-binding cassette, transport widevariety os substances for example ions, small metabolites, lipids, drugsA) (Na+-K +)-ATPaseo Plasma membrane, (αβ)2 tetramero Antiporter that generates charge seperation across membrane -> osmoregulation and nerveexcitability3Na+(in) + 2K+(out) + ATP + H2O -> 3Na+(out) + 2K+(in) + ADP + P i(Na+-K +)-ATPase (2)o ATP transiently phosphorylates Asp to form a high energy intermediate = All P-type ATPases o While every single reaction step is reversible, the entire transport cycle is not(Na+-K +)-ATPase (3)Step 5 is inhibited by cardiac glycosides -> increase in Na+Cardiac Glycosideso Increase intensity of heart muscle contraction Digitalis contains digitoxinOubain (wabane), arrow poison (East African Ouabio tree)o Belong to the steroids, inhibit (Na+-K+)-ATPase Block step 5 -> increase intracellular [Na+]-> stimulate (Na+-Ca2+) antiporter-> increases intracellular Ca2+ and ER stores-> reinforces muscle contraction (higher Ca2+ peaks)B) Ca2+-ATPaseo Transient [Ca2+] increase triggers many processes, such as:o Muscle contractiono Neurotransmitter releaseo Glycogen breakdowno Cytosolic [Ca2+] ~0.1 µM, extracellular 1500µMo Concentration gradient (1000x) is maintained by active transport across the plasma membarne and the ER by Ca2+-ATPases, antiport of protonsCa2+-ATPase (2)C) ABC transporters areresponsible for drug resistance o If anti-cancer drugs do not show any positive effect, this is frequently due to overexpression of the P-glycoprotein, a member of the ABCtransporter superfamily or multidrug resistance(MDR) transporterso Built from 4 modules: 2x cytoplasmic nucleotide binding sites, 2x TMDs with 6 helices each,o In bacteria these 4 domains can be coded by 2 or 4 single proteins; in eukaryotes all 4 domains on asingle proteino In bacteria, ABC transporters can act as importers or exporters, in eukaryotes only as exporters (?)Structure of an ABC transportero S av1866 fromStaphylococcuso H omodimer,intertwinedsubunitsCFT is an ABC transportero CFTR, cystic fibrosis transmembrane conducting channel, is the only ion transporting of the ca 100 known ABC transporters (see Box 3-1)o Allows Cl- ions to flow out of the cell, by ATP hydrolysiso More than 1000 mutations known, most frequent is Phe508 deletion, protein is functional, but improperly folded and degradet in the ER before transport to PMo Homozygous have lung problems, thick mucus in the airways -> suffer from chronic lung infections, early deathD) Ion Gradient-Driven ActiveTransporto Free energy of the electrochemical gradient can be utilized to power active transportfor example uptake of glucose by symport with Na+ (which is transported down the gradient)Lactose permease requires aproton gradiento E. coli lactose permease (galactosidepermease), utilizes proton gradient to symport lactose and H+The lactose permease o High affinity Bdg site extracellularo Low affinity intracellularo Binds sugar only in combination with proton。

顺铂肾毒性

顺铂肾毒性

Cisplatin Nephrotoxicity:A Review XIN YAO,MD;KESSARIN PANICHPISAL,MD;NEIL KURTZMAN,MD; KENNETH NUGENT,MDABSTRACT:Background:Cisplatin is a major antineo-plastic drug for the treatment of solid tumors,but it has dose-dependent renal toxicity.Methods:We reviewed clinical and experimental literature on cisplatin nephro-toxicity to identify new information on the mechanism of injury and potential approaches to prevention and/or treatment.Results:Unbound cisplatin is freely filtered at the glomerulus and taken up into renal tubular cells mainly by a transport-mediated process.The drug is at least partially metabolized into toxic species.Cisplatin has multiple intracellular effects,including regulating genes,causing direct cytotoxicity with reactive oxygen species,activating mitogen-activated protein kinases, inducing apoptosis,and stimulating inflammation and fibrogenesis.These events cause tubular damage and tu-bular dysfunction with sodium,potassium,and magne-sium wasting.Most patients have a reversible decrease in glomerular filtration,but some have an irreversible de-crease in glomerular filtration.Volume expansion and sa-line diuresis remain the most effective preventive strategies. Conclusions:Understanding the mechanisms of injury has led to multiple approaches to prevention.Furthermore,the experimental approaches in these studies with cisplatin are potentially applicable to other drugs causing renal dysfunc-tion.KEY INDEXING TERMS:Cisplatin;Toxicity;Acute renal insufficiency;Apoptosis;Reactive oxygen species. [Am J Med Sci2007;334(2):115–124.]C isplatin is a major antineoplastic drug used forthe treatment of solid tumors.Its chief dose-limiting side effect is nephrotoxicity;20%of patients receiving high-dose cisplatin have severe renal dys-function.Cisplatin-DNA crosslinks cause cytotoxic lesions in tumors and other dividing cells.DNA-damaging agents usually have less toxicity in non-proliferating cells,yet the quiescent proximal tubule cells are selectively damaged by cisplatin.The mech-anism for this renal cell injury has been the focus of intense investigation for many years,and recent studies suggest that inflammation,oxidative stress injury,and apoptosis probably explain part of this injury.Understanding the mechanism(s)for this side effect should allow clinicians to prevent and/or treat this problem better and provides a model for investi-gating drug-induced nephrotoxicity in general.1–3PathogenesisCisplatin Uptake into Renal CellsUptake of cisplatin is mainly through the organic transporter pathway.The kidney accumulates cis-platin to a greater degree than other organs and is the major route for its excretion.The cisplatin con-centration in proximal tubular epithelial cells is about5times the serum concentration.4The dispro-portionate accumulation of cisplatin in kidney tissue contributes to cisplatin-induced nephrotoxicity.5In the rat,cisplatin excretion occurs predominantly by glomerular filtration and to a lesser extent by se-cretion.There is no evidence of tubular reabsorption. Cisplatin is accumulated by peritubular uptake in both the proximal and distal nephrons.5,6The S3segment of the proximal tubule accumulates the highest con-centration of cisplatin,followed by the distal collect-ing tubule and the S1segment in the proximal tubule.6In addition to a transporter-mediated pro-cess,cisplatin enters the cell through passive diffu-sion.7The contribution of active uptake by a trans-port system and passive diffusion through the cellular membrane may vary at different sites. Transporter mediated uptake is likely the major pathway in renal cells.6The organic cation trans-porter(OCT2)is the critical transporter for cispla-tin uptake in proximal tubules in both animals and humans.Transport mediated by these membrane proteins is polyspecific,electrogenic,voltage-depen-dent,bi-directional,pH-independent,and Naϩ-inde-pendent.Three isoforms of OCT have been identified in humans.OCT2is the main OCT in the kidney, OCT1is the main isoform of the liver,and OCT3is widely expressed,especially in the placenta.Cispla-tin is not transported through human OCT1,which may help explain its organ-specific toxicity.Carbo-platin and oxaliplatin,the less nephrotoxic ana-From the Department of Internal Medicine,Texas Tech Univer-sity Health Science Center,Lubbock,Texas.Submitted October6,2006;accepted in revised form January4, 2007.Correspondence:Dr.Kenneth Nugent,Department of Internal Medicine,Texas Tech University Health Science Center,36014th Street,Lubbock,TX79430(E-mail:Kenneth.Nugent@).logues of cisplatin,have no interaction with human OCT2.8Cimetidine,an organic cation competitor for the transport at human OCT2,reduces cisplatin-induced proximal tubule cell apoptosis.9Diabetic animals have reduced gene and protein expression of OCT isotypes and are resistant to cisplatin toxic-ity.10Whether these transporters mediate cisplatin entry into tumor cells is unknown.A recent study demonstrates that a different transporter system, the copper transport protein1regulates the uptake of cisplatin in human ovarian cancer cells.11 Cisplatin MetabolismConversion of cisplatin to nephrotoxic molecules in the proximal tubule cells is required for cell injury.12 The highest concentration of cisplatin is found in cytosol,mitochondria,nuclei,and microsomes.4Cis-platin is conjugated to glutathione and then metab-olized through a␥-glutamyl transpeptidase and a cysteine S-conjugate␤-lyase–dependent pathways to a reactive thiol,a potent nephrotoxin.␥-Glutamyl transpeptidase is located on the cell surface,whereas cysteine-S-conjugate␤-lyase is an intracellular en-zyme.Inhibition of these2enzymes has no effect on the uptake of cisplatin into the kidney but reduces nephrotoxicity.Inhibition of␥-glutamyl transpepti-dase activity,however,renders cisplatin inactive as an antitumor drug.Whether inhibition of cysteine S-con-jugate␤-lyase affects the antitumor activity of cispla-tin is not known.12,13The only report of cysteine S-conjugate␤-lyase activity in tumor cells shows a very low level of activity in some human renal cell carcino-mas.14Cisplatin can form monohydrated complexes by hydrolytic reactions.The monohydrated complex is more toxic to the renal cells than cisplatin but it is not kidney specific.The normal low intracellular chloride concentrations promote its ing hyper-tonic saline to reconstitute cisplatin can decrease the amount of monohydrated complex formed.This ap-proach attenuates nephrotoxicity but may also com-promise its antitumor activity.15Biochemical Changes in the Renal CellCisplatin induces specific gene changes.Genes in-volved in drug resistance(MDR1,P-gp),in cytoskele-ton structure and function(Vim,Tubb5,Tmsb10, Tmsb4x,Anxa2),in cell adhesion(Spp1,Col1a1,Clu, Lgals3),in apoptosis(cytochrome c oxidase subunit I, BAR,heat-shock protein70-like protein,Bax),in tis-sue remodeling(clusterin,IGFBP-1,TIMP-1),and in detoxification(Gstm2,Gstp2)are upregulated after cisplatin-induced injury.Genes downregulated by cis-platin include those that localize to the proximal tu-bules(Odc1,Oat,G6pc,Kap),those that control intra-cellular calcium homeostasis(SMP-30),and those that encode growth factors or their binding proteins(Egf, Ngfg,Igfbp3,Ghr).These gene changes are associated with cisplatin damage to proximal tubules,tissue re-modeling,and regeneration.16–18Cisplatin-induced nephrotoxicity is mediated by mitogen-activated protein kinase(MAPK)intracellu-lar signaling pathways.The MAPK pathways are a series of parallel cascades of serine/threonine kinases that are activated by diverse extracellular physical and chemical stresses.They regulate cell proliferation, differentiation,and survival.The3major MAPK path-ways terminate in the extracellular regulated kinase (ERK),p38,and Jun N-terminal kinase/stress-acti-vated protein kinase(JNK/SAPK)enzymes.The ERK pathway is typically activated by extracellular growth factors and has been linked to both cell survival and cell death.The p38and JNK/SAPK pathways are activated by a variety of stresses,for example,oxi-dants,UV irradiation,hyperosmolality,and inflam-matory cytokines;they have been linked to cell death. Cisplatin was recently shown to activate all three MAPKs in the kidney,both in vitro and in vivo.19ERK and p38function as an upstream signal stimulating tumor necrosis factor-␣(TNF-␣)production.ERK also activates caspase3,which controls apoptosis in renal tubular cells.Phosphorylated-ERK is exclusively local-ized in the distal nephron;therefore ERK1/2activa-tion may mediate distal nephron injury.Whether the ERK pathway contributes to proximal tubule injury is not clear,but certain responses in the distal nephron could induce adjacent proximal tubule injury through autocrine and paracrine processes.20P38activation mediates proximal tubule cells injury.Stimulation of p38is mediated by hydroxyl radicals,which are in-duced by cisplatin.21The JNK/SAPK pathway in the cisplatin-induced nephrotoxicity has not been well studied.Intracellular Events that Damage Renal CellsThe in vivo mechanisms of cisplatin nephrotoxic-ity are complex and involve oxidative stress,apopto-sis,inflammation,and fibrogenesis.High concentra-tions of cisplatin induce necrosis in proximal tubule cells,whereas lower concentrations induce apoptosis through a caspase-9–dependent pathway.22The major pathways in cisplatin-induced acute tubular cell injury are shown in Figure1and summarized in Table1.Oxidative stress injury is actively involved in the pathogenesis of cisplatin-induced acute kidney in-jury.Reactive oxygen species(ROS)directly act on cell components,including lipids,proteins,and DNA,and destroy their structure.ROS are produced via the xanthine-xanthine oxidase system,mito-chondria,and NADPH oxidase in cells.In the pres-ence of cisplatin,ROS are produced through all these pathways and are implicated in the pathogen-esis of acute cisplatin-induced renal injury.23Cispla-tin induces glucose-6-phosphate dehydrogenase and hexokinase activity,which increase free radical pro-duction and decrease antioxidant production.24It increases intracellular calcium level which activatesCisplatin NephrotoxicityNADPH oxidase and to stimulates ROS production by damaged mitochondria.23Superoxide anion(O2●),25 hydrogen peroxide(H2O2),26and hydroxyl radical (●OH)27are increased in cisplatin-treated kidneys. These free radicals damage the lipid components of the cell membrane by peroxidation and denature proteins,which lead to enzymatic inactivation.Free radicals can also cause mitochondrial dysfunction.24 Antioxidant enzymes are inhibited by cisplatin, and renal activities of superoxide dismutase,glu-tathione peroxidase,and catalase are significantly decreased.28,29Antioxidants melatonin,30vitamin C26,and vitamin E31have been shown to prevent cisplatin-induced acute nephrotoxicity.The role of oxidant-antioxidant systems in chronic nephrotoxic-ity is uncertain.Reactive nitrogen species have also been studied in cisplatin-induced nephrotoxicity.The renal content of peroxynitrite and nitric oxide is increased in cisplatin-treated rats.32,33Peroxynitrite causes changes in pro-tein structure and function,lipid peroxidation,chemical cleavage of DNA,and reduction in cellular defenses by oxidation of thiol pools.Cisplatin-induced nitrosative stress and nephrotoxicity are attenuated by FeTPPS-treatment,a soluble complex which metabolizes per-oxynitrite.These data suggest that peroxynitrite is involved,to some degree,in cisplatin-induced nephro-toxicity and protein nitration.32However,it isstill Figure1.Major pathways in cisplatin-induced acute tubular cell injury.Table1.Selected Summary of Drug Metabolism and Toxic ProcessesProcess RelevancePharmacokinetics and excretion Renal excretion Drug concentration in tubulesCellular uptake and metabolism Transporter mediated Inhibition-reduced uptakeIntracellular hydration Increased toxicityGenomic effects Gene upregulation Caspase3¡apoptosisGene downregulation Superoxide dismutase¡1ROSDirect toxic effects ROS Lipid peroxidationMitochondrial injury1ROS,2ATP productionIndirect toxic effects MAPK pathways1TNF-␣production activate apoptosisOrgan effects:histology Tubular injury Apoptosis,necrosisOrgan effects:function2Tubular function Na,K,Mg wastingTherapy Limit toxicity,if preventionfails,see Table2Not available yet,possible approach-stop apoptosis ATP,Adenosine triphosphate;MAPK,mitogen-activated protein kinase;ROS,reactive oxygen species;TNF-␣,tumor necrosis factor-␣.Yao et alcontroversial whether nitric oxide plays a toxic role in kidney injury.24,32,33Hypoxia and mitochondrial injury are involved in cisplatin nephrotoxicity.Pathological changes in cis-platin-induced nephrotoxicity occur mainly in the S3 segment of the proximal tubule in the outer stripe of the outer medulla.This zone of the kidney is more susceptible to ischemic insult,and injury to this segment occurs in other toxic acute renal failure models.34Hypoxic tubules in the outer medulla have been identified by pimonidazole staining in cisplatin nephrotoxicity.Analyses using serial sections indi-cate that a significant portion of hypoxic cells are proximal tubular cells.35Therefore,hypoxia may have an important role in cisplatin-induced nephro-toxicity,and this probably develops during the de-creased renal blood observed during the initial phase of cisplatin nephrotoxicity.However,hypoxia-inducible factor1(HIF-1)is activated in the S3seg-ment of proximal tubules in cisplatin injury in vivo. HIF-1is a transcription factor that mediates cellu-lar responses to hypoxia,including angiogenesis, erythropoiesis,and glycolytic adaptation.Dominant negative HIF-1␣-subunit animals have increased susceptibility to cisplatin injury mediated by apopto-sis which was associated with the increased release of cytochrome c,loss of mitochondrial membrane potential,and increased caspase9activity.35There-fore,the net effect of hypoxia in cisplatin-induced renal injury is uncertain.Apoptosis is now recognized as an important mode of cell death in normal and pathologic states. Caspase1,8,and9are initiator caspases that acti-vate caspase3,which is the principal executioner caspase in renal tubules apoptosis.This process may proceed through either activation of an extracellular surface receptor pathway or an intracellular mito-chondrial pathway.DNA fragments and oxidative stressors initiate the mitochondrial pathway that results in caspase9activation.36Engagement of a cell surface receptor with extracellular tumor necro-sis factor-␣(TNF-␣)activates caspase8.37Both pathways may be involved in cisplatin-injured kid-ney.In addition,cisplatin can induce a very rapid Fas clustering into the membrane lipid rafts and elicit apoptosis cascade in the absence of Fas ligand. This pathway has been implicated in its cytotoxicity of cancer cells.Whether it is involved in nephrotox-icity is unknown.38Caspase1directly activates caspase3in cisplatin-induced renal injury model. Caspase1also increases interleukin1␤(IL-1␤)lev-els and contributes to the inflammation in the cis-platin-treated kidney.Cisplatin-induced apoptosis and ATN are reduced in caspase1-deficient mice.39 DNA fragmentation associated with cisplatin-in-duced nephrotoxicity depends on deoxyribonuclease I,a highly active endonuclease I,which represents approximately80%of the total endonuclease activ-ity in the kidney.Primary renal tubular epithelial cells isolated from deoxyribonuclease I knockout an-imals are resistant to cisplatin injury in vitro.40 Cisplatin induces a series of inflammatory changes that mediate renal injury.Recent evidence indicates that inflammation has an important role in the patho-genesis of cisplatin-induced renal injury.Cisplatin in-creases degradation of I␬B in a time-dependent man-ner and increases nuclear factor-␬B(NF-␬B)binding activity.These events lead to the enhanced renal expres-sion of TNF-␣.Other cytokines,such as transcribing growth factor-␤(TGF-␤),monocyte chemoattractant pro-tein-1(MCP-1),intercellular adhesion molecule(ICAM), hemeoxygenace-1,TNF receptor1(TNFR1),and TNF receptor2(TNFR2),are also increased in kidneys by cisplatin.41TNF-␣has a central role in mediating the renal injury.It induces apoptosis,produces reactive oxy-gen species,and coordinates the activation of a large network of chemokines and cytokines in the kidney. Inhibitors of TNF-␣production(GM6001and pentoxifyl-line)and TNF-␣neutralizing antibody reduce serum and kidney TNF-␣protein levels from30%to nearly100%. They blunt the cisplatin-induced increases in TGF-␤, RANTES,MIP-2,and MCP-1mRNA.42In addition,the TNF-␣inhibitors ameliorate cisplatin-induced renal dys-function by50%and reduce cisplatin-induced structural damage.42TNF-␣-deficient mice are markedly protected against cisplatin nephrotoxicity.43Cisplatin can also induce fibrosis around the af-fected tubules,accompanied by infiltration of mac-rophages and lymphocytes.In a rat model that re-ceived2mg/kg body weight cisplatin injections once weekly for7weeks,fibrotic lesions progressively developed in the corticomedullary junction as early as week1and reached a maximum at week5.44All renal damages were repaired during a19-week ob-servation period after cessation of cisplatin treat-ment by a reduction in fibrotic tissues and by re-placement with regenerated renal tubules.The healing was accompanied by decreases in BUN and creatinine concentrations.44Extensive renal tubulo-interstitial fibrosis has been shown in a patient45 and in other large animals46treated with multiple courses of cisplatin chemotherapy.Macrophages play an important role in renal interstitial fibrosis via production of TGF-␤1and TNF-␣;these fibro-genic factors mediate induction of myofibroblastic cells capable of producing extracellular matrices.47 In summary,cisplatin causes direct tubular injury through multiple mechanisms.Significant interac-tions among these various pathways may occur dur-ing this injury.For example,TNF-␣induces apopto-sis,produces ROS,and coordinates the activity of a network of cytokines that all contribute to cellular injury.However,it also triggers the expression of inducible nitric oxide synthase,increases the pro-duction of nitric oxide,and enhances HIF-1activity in normoxic renal tubule cells,events that could limit injury.48How much each pathway and the interactions among these pathways contribute toCisplatin Nephrotoxicitythe cisplatin nephrotoxicity has not been deter-mined(Figure1).Pathophysiological Effects of Cisplatin Injury Unbound cisplatin is filtered at the glomerulus (80%of a dose is excreted in24hours).Renal blood flow can decrease within3hours after cisplatin infusion,and glomerular filtration rate(GFR)falls after the decrease in renal blood flow.49The media-tors responsible for the fall in renal blood flow and GFR have not been determined,and neither calcium channel blockers nor angiotensin converting enzyme inhibitors reverse cisplatin-induced ARF.50The changes in GFR and renal blood flow probably re-flect increased renal vascular resistance secondary to tubular-glomerular feedback from increased so-dium chloride delivery to the macula densa.49Intra-tubular obstruction does not play a primary role in cisplatin-induced nephrotoxicity.50Most patients re-ceiving cisplatin treatment have stable renal func-tion.Twenty-five percent of patients have reversible azotemia for1to2weeks after treatment.51How-ever,a significant minority of patients have a pro-gressive decline in renal function.Irreversible renal failure can occur with large doses and with multiple courses.51,52Increased age,renal radiation,and al-cohol ingestion increase toxicity.53The proximal tubular dysfunction observed in cis-platin nephrotoxicity precedes alterations in renal hemodynamics.Forty-eight to72hours after cispla-tin administration,there is impaired proximal and distal tubular reabsorption and increased vascular resistance.51Acute toxicity causes decreased mito-chondrial function,decreased ATPase activity,al-tered cell cation content,and altered solute trans-port.49,51The expression patterns of outer medullary water channels aquaphorin1and2,of sodium trans-porters,including the Na,K-ATPase(a-subunit)and the Na,K,2Cl-cotransporter,and of the type III Na,H-exchanger,are decreased in a cisplatin-treated rat model.Hence,cisplatin treatment results in im-paired tubular reabsorption and decreased urinary concentration.51,54The effect on sodium and water transport represents an early change in cisplatin tox-icity since the inhibition of the transporters occurs in rats without elevation of BUN and creatinine.51,55 There is decreased sodium reabsorption in the proxi-mal tubule and decreased sodium and water reabsorp-tion in distal tubule.This causes increased excretion of sodium and water.5,55Polyuria uniformly accompanies cisplatin administration and occurs in2distinct phases.The first phase occurs within the first24to48 hours after administration.It is characterized by de-creased urine osmolality but stable GFR.It is probably prostaglandin mediated and can be prevented by va-sopressin and aspirin.This early phase polyuria usu-ally resolves spontaneously.The second phase starts between72and96hours after cisplatin administra-tion and is characterized by a decreased GFR.It is associated with medullary urea cycling defect which results in decreased medullary tonicity and impaired NaCl transport in the proximal tubule and thick as-cending limb of the loop of Henle.This phase does not respond to either drug.50,56Most patients waste so-dium,potassium,magnesium,and calcium in their urine and some have orthostatic hypotension.50,51,57,58 Pathological Changes in the Kidney Cisplatin nephrotoxicity primarily causes tubulo-interstitial lesions.In animal models cisplatin dam-ages the proximal tubules,specifically the S3seg-ment of the outer medullary stripe.Mitochondrial swelling and nuclear pallor occur in the distal nephron.The glomerulus has no obvious morpho-logic changes.49,56,59Only a few studies have de-scribed the pathological results associated with cis-platin-induced nephrotoxicity in humans.49,56,59,60 The site of injury involves either the distal tubule and collecting ducts or the proximal and distal tu-bules.49,56The sites affected probably depend on differences in dose and timing of biopsy specimens. Biopsies obtained3to60days after dosing reveal segmental degeneration,necrosis,and desquama-tion of the epithelial cells in the pars convoluta and pars recta of the proximal tubules and the distal tubules.60In patients with acute renal failure,the predominant lesion is acute necrosis and is located mostly in the proximal convoluted tubules.The se-verity of necrosis is dose-,concentration-,and time-dependent.There is no interstitial nephritis.56,59Pa-tients with chronic nephrotoxicity have focal acute tubular necrosis characterized by cystic dilated tu-bules lined by a flattened epithelium showing atyp-ical nuclei and atypical mitotic figures with hyaline casts.49Long-term cisplatin treatment and injury may cause cyst formation and interstitial fibrosis.49 Diagnostic Criteria for Cisplatin Injury Cisplatin-induced renal injury probably does not have unique diagnostic features.Many patients have changes in glomerular filtration which could be identified by more sensitive tests such as inulin clearance before there are changes in serum creati-nine and glomerular filtration measured by creati-nine collection.Urinary excretion of a proximal tu-bular injury markers,such as␤-2microglobulin, N-acetyl-␤-D-glucosaminidase,and␣1-acid glycop-rotein,increase after cisplatin treatment.53There is little change in urine protein excretion.Urinalysis typically shows leukocytes,renal tubular epithelial cells,and granular casts.56A recent animal study demonstrated the presence of glucose,amino acids, and tricarboxylic acid cycle metabolites in the urine 2days after cisplatin exposure.If this altered met-abolic profile can be demonstrated in human stud-Yao et alies,it might be used to identify early cisplatin-induced nephrotoxicity.61Approaches to PreventionThese various approaches are summarized in Ta-ble2.Excretion and MetabolismVigorous hydration with saline and simultaneous administration of mannitol before,during,and after cisplatin administration significantly reduce cispla-tin-induced nephrotoxicity.This strategy has been accepted as the standard of care.49Recently,a ran-domized trial demonstrated that saline alone or with furosemide provides better renal protection than saline plus mannitol.62The mechanism for salt pro-tection is uncertain.Volume expansion with saline or hypertonic saline may increase the rate of cispla-tin excretion.63Salt also provides a high concentra-tion of chloride ions that prevent the dissociation of the chloride ions from the platinum molecule, thereby reducing the formation of the reactive, aquated species of cisplatin.64Alternatively,sodium ions may provide renal protection.A recent study demonstrated that saline does not alter the cellular accumulation of cisplatin but instead triggers a stress response within the cell that modifies sensi-tivity to cisplatin.The osmotic stress response de-creases the accessibility of cisplatin to DNA,induces proximal tubule cell resistance to apoptosis,and changes the metabolic activation of nephrotoxins. However,this approach may interfere with the an-tineoplastic activity of cisplatin by blocking tumori-cidal effects.65Cellular UptakeCarboplatin and oxiplatin are second-and third-generation platinum drugs that have been intro-duced into clinical use because of their reduced nephrotoxicity.They have no interaction with hu-man OTC2,and this reduces their entry into renal tubular cells.8,9The in vitro antitumor activity of carboplatin is quantitatively similar to cisplatin; clinical trials have demonstrated that carboplatin has comparable efficacy in treating ovarian cancer.50 It can be used in patients who can not take cisplatin either due to existing renal dysfunction or coadmin-istration of other nephrotoxic drugs.Although less severe than with cisplatin,dose-dependent nephro-toxicity has been observed.With carboplatin dosage at400mg/m2,only subclinical tubular damage oc-curs.Overt nephrotoxicity develops when the dosage reaches800mg/m2.Without hydration,patients have a36to61%reduction in creatinine clearance.49Table2.Potential Approaches to Prevention of Cisplatin-Induced Nephrotoxicity Pathogenesis Prevention Agent Mechanism of Prevention Reference Uptake by renal cell Glycation Decreases human OCT expression10,68Cimetidine Competes for the transport at human OCT28,9Carboplatin,Oxaliplatin Decreased interaction with human OCT28,9,50,55,66,67Sulfa-containing amino acid Blocks cisplatin transportation6Conversion to toxic compounds Normal saline Increases excretion,reduces formation oftoxic agents and induces osmotic stressresponse49,62,63,64,Procainamide Coordinates with cisplatin to form a lesstoxic complex70,71Cisplatin induced signal transduction Serum thymic factor Ameliorates sustained ERK activation79 U0126Decreases TNF-␣generation and caspase3activity20Oxidative stress injury Amifostine Binds free radicals and reduces platinum-DNA adduct formation76,77,78 Melatonin,vitamins C and E Decreases oxidative stress injury26,30,31 Allopurinol Inhibits xanthine oxidase to reduce ROSgeneration72 Ebselen Scavenges peroxynitrite to prevent lipidperoxidation72 Erdosteine Maintains intracellular redox state tosuppress oxidant stress24 Edaravone andN-acetylcysteineRepletes intracellular stores of glutathione73Inflammation Pentoxifylline,␣-MSH,IL-10,Inhibits production of TNF-␣82Salicylates Inhibit cyclooxygenase activity andprostaglandin synthesis,high dosesattenuate TNF-␣production41,81Fibrates Inhibit free fatty acid accumulation andsuppress apoptosis83ERK,Extracellular regulated kinase;IL-10,interleukin10;MAPK,mitogen-activated protein kinase;␣-MSH,␣-melanocyte stimulating hormone;OCT,organic cation transporter;ROS,reactive oxygen species;TNF-␣,tumor necrosis factor-␣.Cisplatin Nephrotoxicity。

绦概带曼cestodes

绦概带曼cestodes

Morphology of tapeworms: The scolex
The scolex is the part of the worm that anchors it to the intestinal epithelium and prevents that the worm is passed with the digested food.
The male system consists of numerous testes, vasa efferentia from each testis to the sperm duct. The cirrus is surrounded by the cirrus pouch. Most often the cirrus pouch and female vagina enter a common chamber, the genital atrium, and share a common opening, the genital pore.
larvae are • cysticercoid, • cysticercus • and hydatid • (some of these larvae
provided amplification • (Coenurus=many scolices)
Differentiation of the two orders (tapeworms)
Cyclophylidea
______________________________________________________
Diferentiating Pseudophylidea
Cyclophylidea
Feature

槲皮素文献

槲皮素文献

ORIGINAL CONTRIBUTIONQuercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic miceQing-Hua Hu •Xian Zhang •Xing Wang •Rui-Qing Jiao •Ling-Dong KongReceived:5March 2011/Accepted:26August 2011/Published online:10September 2011ÓSpringer-Verlag 2011AbstractBackground Renal organic ion transporters and uromod-ulin (UMOD)play the important roles in renal urate excretion and function.Hyperuricemia is considered as a risk factor for the development of renal dysfunction.The flavonoid quercetin in diets exerts the hypouricemic and nephroprotective effects.Purposes To evaluate the effects of quercetin on renal organic ion transporters and UMOD in hyperuricemic mice.Methods Kun-Ming mice were divided into normal and hyperuricemic groups receiving water,25,50and 100mg/kg quercetin,5mg/kg allopurinol,respectively.Hyperuri-cemic mice were orally gavaged with 250mg/kg oxonate daily for 1week.Quercetin and allopurinol were orally gavaged on the day when oxonate or water was given 1h later.After 1week,serum uric acid,creatinine and blood urea nitrogen concentrations,excretion of urate and creat-inine,and fractional excretion of uric acid were measured.The mRNA and protein levels of renal urate transporter 1(mURAT1),glucose transporter 9(mGLUT9),organic anion transporter 1(mOAT1)and organic cation/carnitine transporters (mOCT1,mOCT2,mOCTN1and mOCTN2)in mice were analyzed.Simultaneously,UMOD levels in serum,urine and kidney,as well as renal UMOD mRNA expression were detected.Results Quercetin significantly restored oxonate-induced abnormalities of these biochemical indexes compared with normal vehicle group.Furthermore,it remarkably pre-vented expression changes of renal organic ion transportersand UMOD,and UMOD level alteration in hyperuricemic mice.Conclusions These results suggest that quercetin has the uricosuric and nephroprotective actions mediated by reg-ulating the expression levels of renal organic ion trans-porters and UMOD.Keywords Hyperuricemia ÁRenal dysfunction ÁQuercetin ÁRenal organic ion transporters ÁUromodulin Abbreviations OAT Organic anion transporter URAT1Urate transporter 1GLUT9Glucose transporter 9OCT Organic cation transporter OCTN Organic cation/carnitine transporter FEUA Fractional excretion of uric acid Sur Serum uric acid concentration Scr Serum creatinine concentration Uur Urine uric acid concentration Ucr urine creatinine concentration UMOD UromodulinRT-PCR Reverse transcriptase-polymerase chainreactionBBMV Brush border membrane vesicles BUN Blood urea nitrogenIntroductionHyperuricemia is associated with the development of renal dysfunction,gout,hypertension,hyperlipidemia,diabetes and obesity [1,2].The impairment of reabsorption andQ.-H.Hu ÁX.Zhang ÁX.Wang ÁR.-Q.Jiao ÁL.-D.Kong (&)State Key Laboratory of Pharmaceutical Biotechnology,School of Life Sciences,Nanjing University,Nanjing 210093,People’s Republic of China e-mail:kongld@123Eur J Nutr (2012)51:593–606DOI 10.1007/s00394-011-0243-ysecretion of urate in the kidney is an important cause of hyperuricemia.Renal organic anion transporters(OATs)of the SLC22gene family are suggested to regulate renal urate excretion.OAT1(SLC22A6)and OAT3(SLC22A8)at the basolateral membranes of renal proximal tubules are responsible for primary urate transport[3,4].The reab-sorptive urate transporter1(URAT1,SLC22A12),as well as the SLC2gene family SLC2A9encoding glucose trans-porter9(GLUT9)at apical membranes of renal proximal tubules in human mainly control urate homeostasis[5–7]. Mutations in SLC2A9gene develop low serum uric acid concentration and high fractional excretion of uric acid (FEUA)[5].On the other hand,uptake and excretion of kidney organic cations are mediated by renal organic cation and carnitine transporters(OCTs and OCTNs)of the SLC22gene family[8–10].Expression of renal rOCT1 (SLC22A1)and rOCT2(SLC22A2)is down-regulated in streptozotocin-induced diabetic rats with kidney dysfunc-tion[8].OCTN1(SLC22A4)is a susceptibly factor in the etiopathology of autoimmune disorders[9].Defect muta-tions in hOCTN2(SLC22A5)cause the impaired reab-sorption and secretion of organic cations[10].OAT1and OAT3mediate uptake of anion toxic from the blood into renal proximal tubules to induce nephrotoxicity[11].These observations indicate that abnormalities in the expression levels of these renal organic ion transporters may be involved in the pathogenesis of hyperuricemia and renal dysfunction.Uromodulin(UMOD),the most abundant protein in normal urine,is exclusively expressed in the thick ascending limb of Henle’s loop.Mutations in UMOD gene lead to familial juvenile hyperuricemic nephropathy [12,13].Mouse missense mutation of UMOD also devel-ops kidney dysfunction[14].Therefore,UMOD may be a useful marker of renal dysfunction in hyperuricemia with the abnormality of renal organic ion transporters.Quercetin(3,30,40,5,7-pentahydroxyflavone),a kind of flavonoids,is abundant in fruits,vegetables and herbal food with health beneficial properties for humans,such as anti-inflammation,anti-oxidation,anti-carcinogen,anti-hyper-tension and anti-apoptosis[15,16].Our previous studies confirmed that quercetin reduced serum uric acid levels in hyperuricemic mice induced by uricase inhibitor potassium oxonate[17,18],and increased FEUA with the enhance-ment of renal urate excretion in excess fructose consump-tion-induced hyperuricemic rats[19].In addition,quercetin decreases serum creatinine and blood urea nitrogen(BUN) concentrations in ischemia/reperfusion-induced renal injury[20],cadmium-induced nephrotoxicity[21]and fructose-induced renal dysfunction[19]in rats.It is noted that96%of quercetin is metabolized in rat kidneys[22].A recent study shows that kidney contains significantly higher concentrations than plasma after long-term dietary intake of quercetin[23].Therefore,the kidney may be considered as a primary target of quercetin’s uricosuric and renal protective effects.Furthermore,quercetin is found to sig-nificantly inhibit cellular uptake of(3H)-p-aminohippurate mediated by hOAT1in MDCK cells[24]and of(14C)-tetraethylammonium mediated by pOCT2in LLC-PK1 cells[25,26].In our previous study,quercetin was found to attenuate fructose-induced dysregulation of renal rSLC2A9v2,renal-specific transporter,rOAT1,rOCT1and rOCT2in rats[19].These observations have implications for the involvement of renal organic ion transporters in the uricosuric and renal protective actions of quercetin in hyperuricemia with kidney dysfunction.It is well known that renal urate transport system in mice is similar to that in humans[3,27].The research of renal organic ion trans-porters from mice will provide insights into renal urate transport system in humans.Therefore,the purpose of the present study was to determine whether quercetin regulates the expressing levels of renal organic ion transporters, which contributes to its protection against hyperuricemia and renal dysfunction in oxonate-induced hyperuricemic mice.In order to improve our understanding of the role of UMOD in hyperuricemia with renal dysfunction andfind new therapeutic target,UMOD level and expression were also examined in hyperuricemic mice treated with quercetin.Materials and methodsMaterialQuercetin,uric acid,allopurinol and potassium oxonate were purchased from Sigma(St.Louis,MO,USA).Trizol reagent was purchased from Invitrogen.Reverse trans-criptase moloney murine leukemia virus(M-MLV)used for cDNA synthesis was from Promega.Taq DNA poly-merase and polymerase chain reaction buffer mixture were from Genescript Company limited.R.P.China.Assay kits of creatinine and BUN were purchased from Jiancheng Biotech(Nanjing,P.R.China).ELISA assay kit of UMOD was purchased from R&D(Minneapolis,USA).mURAT1 (001046-R),mGLUT9(001051-R),mOAT1(001019-R), mOAT3(001020-R),mOCT1(001017-R),mOCT2 (001018-R)antibodies were obtained from Cellchip Bio-tech(Beijing,P.R.China).mOCTN1(OCTN11-A)and mOCTN2(OCTN21-A)antibodies were purchased from Alpha Diagnostic International Inc.(San Antonio,USA). Mouse mGAPDH monoclonal antibody(KC-5G5)was from Kangcheng Biotech(Shanghai,P.R.China).Rabbit mNa?–K?ATPase antibody(#3010S)was from Cell Signaling Technology,Inc.(Boston,MA,USA).Goat anti-rabbit-IgG-HRP(SB-200)was obtained from Jingmei Biotech(Shanghai,P.R.China).594Eur J Nutr(2012)51:593–606 123Animals and drug administrationThe Animal Experiment Committee of Nanjing University approved the protocol of animal study.Male Kum-Ming strain of mice(20±2g)was purchased from the animal centre of Qing-Longshan(Nanjing,Jiangsu Province,P. R.China).Hyperuricemia was developed by uricase inhibitor potassium oxonate,as described previously[28]. Mice were divided into ten groups:hyperuricemic groups receiving water(vehicle),25,50and100mg/kg quercetin, 5mg/kg allopurinol,and normal groups receiving water (vehicle),25,50and100mg/kg quercetin,5mg/kg allo-purinol,respectively.Oxonate,quercetin and allopurinol at various concentrations were dissolved or suspended in distilled water.Standard diets(60%vegetable starch,11% fat and29%protein),but not water,were withdrawn from the animals1h prior to the administration.Briefly,mice were administered in a volume of15mL/kg by gavage once daily with oxonate(250mg/kg)or water(vehicle)at 8:00a.m.for seven consecutive days.Quercetin or allo-purinol was orally gavaged at9:00a.m.on the day when oxonate was given.Dosages of quercetin were determined based on the conversions from clinical adult dosages[29–32]and our previous and preliminary studies.According to the reports in subjects,daily supplementation dosages of quercetin in subjects are1,000mg[29],730mg[30]and 150mg[15,31],respectively.Equivalently,for mice,these dosages are130,94.9and19.5mg/day calculated by the formula that converts dosage of human into that of mouse according to the respective body surface areas according to the Chinese Medicine Pharmacology Research Technology [32].Moreover,pretreatment of30mg/kg quercetin markedly restores ischemia/reperfusion-induced renal dysfunction and morphological alterations in rodents[20]. Quercetin at50mg/kg improves gentamicin-induced renal dysfunction and degenerative changes in glomeruli and tubules of rats[33].Our previous studies showed that quercetin at50and100mg/kg could lower serum urate levels in acute oxonate-treated mice and chronic fructose-fed rats with renal dysfunction[17,19].In addition,our preliminary experiment demonstrated that three doses of quercetin at25,50and100mg/kg were suitable for the present study.Blood,urine and tissue sample collectionFrom24h beforefinal administration on the seventh day, urine sample for each mouse in24-h was collected in a metabolic cage and urine volume was recorded.Urine samples were centrifuged at2,0009g for10min to remove the particulate contaminants.Whole blood samples were collected1h afterfinal administration on the seventh day by tail vein bleeding,and then centrifuged at10,0009g for 5min to obtain the serum.Serum and urine samples were stored at-20°C until biochemical assays.Simultaneously, mice were anesthesized by intraperitoneal injection of xylacin hydrochloride(10mg/kg)and ketamine(100mg/ kg).Kidney cortex tissues were rapidly and carefully removed on ice-plate,and stored at-70°C for assays.Determination of uric acid,creatinine and BUN levelsSerum uric acid levels(Sur)and urinary uric acid levels (Uur)were determined by the phosphotungstic acid method [17].Excretion of urine uric acid in24-h was calculated using the formula:Volume of urine in24-h9Uur.Serum and urine creatinine levels(Scr,Ucr)were determined spectrophotometrically using trinitrophenol colorimetry kit.Excretion of urine creatinine in24-h was calculated using the formula:Volume of urine in24-h9Ucr.FEUA was calculated using the formula:FEUA=(Uur9Scr)/ (Sur9Ucr)9100,expressed as percentage[34].BUN levels were determined using urease ultraviolet kit. Determination of UMODThe whole kidney was homogenized in100volume/wet weight of sodium chloride and centrifuged at5,0009g for 10min at4°C.The supernatant was for kidney UMOD level assay.Serum,urine and kidney UMOD levels were determined using ELISA kit.RNA isolation and semiquantitative reverse transcriptase-polymerase chain reaction(RT-PCR) analysisRNA analyses of mOAT1,mOAT3,mGLUT9,mURAT1, mOCT1,mOCT2,mOCTN1and mOCTN2in kidney cortex were performed by a semiquantitative RT-PCR as described previously[28].PCR amplification was carried out using gene-specific PCR primers.cDNA was amplified using the Promega Access RT-PCR System with the fol-lowing program:one cycle at95°C,2min;followed by 30–40cycle each including denaturation at94°C30s, 35s at appropriate anneal temperature,extension45s at 72°C and one cycle at72°C,10min.The sequences of gene-specific PCR primers,numbers of cycles and anneal temperature were showed in Table1.Relative quantitation for PCR products was calculated after normalization to the amount of mGAPDH mRNA levels.Preparation of kidney tissue extraction and Westernblot analysisThe protein extractions of renal cortical brush-border membrane vesicles for mURAT1,mOCTN1,mOCTN2Eur J Nutr(2012)51:593–606595123and mNa?–K?ATPase analysis,and of renal cortex for mOAT1,mOAT3,mGLUT9,mOCT1,mOCT2and mGAPDH analysis were prepared as previously described [28].Western blot analysis was performed as previously described[28].The contents of target proteins were ana-lyzed densitometrically using the sensiansys software (Peiqing pany Ltd.Shanghai,P.R.China)and normalized by the respective blotting from mGAPDH or mNa?–K?ATPase,respectively.Statistical analysisData were expressed as the mean±standard error of the mean(SEM).Effects of quercetin or allopurinol on bio-chemical indicators in normal and hyperuricemic mice were analyzed by a2-way analysis of variance(ANOVA) to determine the level of significance.The results of PCR and Western Blotting experiments were analyzed by LSD post hoc test.A value of P\0.05was considered statis-tically significant.ResultsSerum uric acid levelsIn order to monitor the efficacy of quercetin treatment,uric acid levels in serum were determined in hyperuricemic mice(Table2).As expected[28],oral administration of 250mg/kg oxonate for1week significantly induced ele-vation of serum uric acid levels(P\0.001)compared to normal vehicle group.Quercetin at25,50and100mg/kg effectively decreased serum levels of uric acid(P\0.05, P\0.01,P\0.001)in hyperuricemic mice compared to hyperuricemia vehicle group,with dose-dependent manner (quercetin:P\0.01,100mg/kg compared to25mg/kg; P\0.001,100mg/kg compared to50mg/kg).Allopurinol at5mg/kg had similar effect(P\0.001).These data confirmed that quercetin reversed oxonate-induced serum uric acid elevation in mice.2-way ANOVA revealed sig-nificant effects of oxonate,quercetin and oxonate9quer-cetin in quercetin-treated mice,while2-way ANOVA also revealed significant effects of oxonate factor,allopurinol factor and oxonate9allopurinol interaction in allopurinol-treated mice(Table2).In addition,quercetin did not affect serum uric acid levels in normal mice,however,allopurinol remarkably decreased the levels(P\0.001)(Table2).Urate excretion and renal functionAs shown in Table2,there were no differences in24-h volume of urine among all groups.Hyperuricemic mice exhibited24-h under-excretion of uric acid(P\0.01)and creatinine(P\0.01)compared to normal vehicle animals (Table2).FEUA,related renal uric acid handling param-eter,was also remarkably decreased in this model (P\0.01)(Table2).Oxonate induced significant eleva-tion in serum levels of creatinine(P\0.001)and BUN (P\0.01)in mice(Table2).These data further confirmed that oxonate-treated mice developed renal urate excretion reduction and function impairment.Quercetin at25,50and 100mg/kg significantly increased excretion of uric acid (P\0.05,P\0.05,P\0.001)and creatinine(P\0.01, P\0.01,P\0.001)in hyperuricemic mice compared to hyperuricemia vehicle group(Table2),without significant dose-dependent manner.Furthermore,administration of quercetin to hyperurice-mic mice was effective in reversing oxonate-induced ele-vation of serum levels of creatinine(P\0.01,P\0.001, P\0.001)and BUN(P\0.01,P\0.01,P\0.05), thereby elevated FEUA(P\0.01,P\0.01,P\0.001) (Table2).Effects of quercetin on serum creatinine levels (P\0.05,100mg/kg;P=0.072,50mg/kg compared to 25mg/kg)and FEUA(P\0.05,100mg/kg compared toTable1Summary of the gene-specific PCR primer sequences,the length of production and the appropriate annealing temperature used in the experimentsDescription Genebank Sense primer(50?30)Antisense primer(50?30)Productsize(bp)Tm(°C)Numbers ofthermal cyclemOAT1NM_008766ACGGGAAACAAGAAGAGGG AAGAGAGGTATGGAGGGGTAG5805629mOAT3SLC22A8TGCTACTGGCTTTGCCTACT CTCCTGCTTTGTTTTCTTGG5565629mGLUT9NM_001102414GAGATGCTCATTGTGGGACG GTGCTACTTCGTCCTCGGT3165630mURAT1NM_009203GCTACCAGAATCGGCACGCT CACCGGGAAGTCCACAATCC3425830mOCT1NM_009202ACATCCATGTTGCTCTTTCG TTGCTCCATTATCCTTACCG3155629mOCT2NM_013667ACAGGTTTGGGCGGAAGT CACCAGAAATAGAGCAGGAAG3315629mOCTN1NM_019687TGTTCTTCGTAGGCGTTCT TGGAATAAACCACCACAGG39253.330mOCTN2NM_011396TCTACGAAGCCTCAGTTGC ATTCCTTTGACCCTTAGCAT62353.330 mUMOD NM_009470CGGATAACGGCAGATGG GGTAGGGCTCTGGAACAAT47953.330 mGAPDH NM_008084TGAGGCCGGTGCTGAGTATGT CAGTCTTCTGGGTGGCAGTGAT2995835596Eur J Nutr(2012)51:593–606 123T a b l e 2E f f e c t s o f q u e r c e t i n (Q u e )a n d a l l o p u r i n o l (A P )o n s e r u m u r i c a c i d l e v e l s (S U A ),v o l u m e o f u r i n e (V U r i n e )i n 24h ,e x c r e t i o n o f u r i c a c i d (U U A )i n 24h ,e x c r e t i o n o f c r e a t i n i n e (U C r )i n 24h ,f r a c t i o n a l e x c r e t i o n o f u r i c a c i d (F E U A ),s e r u m c r e a t i n i n e (S C r )a n d b l o o d u r e a n i t r o g e n l e v e l s (B U N )i n n o r m a l a n d o x o n a t e (O X )-i n d u c e d h y p e r u r i c e m i c m i c eV a r i a b l e N o n -O XO X2-w a y A N O V A (P v a l u e )Q u e r c e t i nQ u e r c e t i nV e h i c l e 2550100(m g /k g )V e h i c l e 2550100(m g /k g )O X Q u e O X 9Q u eS U A (l m o l /L )292.29±4.03***288.25±8.90289.01±11.84295.11±11.50414.04±1.57???359.74±14.44*354.59±10.34**294.54±9.51***\0.001\0.001\0.001V U r i n e i n 24h (l L )519.38±62.54541.25±8.90492.50±68.78513.75±46.34596.88±95.06601.88±87.63525.63±95.71590.63±82.900.2590.8630.991U U A i n 24h (m g )0.58±0.03**0.56±0.040.53±0.050.56±0.020.36±0.05??0.56±0.08*0.59±0.06*0.78±0.09***0.6390.0080.003U C r i n 24h (m g )0.58±0.06**0.54±0.040.52±0.040.52±0.030.33±0.04??0.77±0.12**0.58±0.06**0.74±0.08***0.1380.0170.001F E U A18.06±1.44**18.66±0.6019.15±1.12*18.69±1.3411.57±0.52??14.96±0.42***15.43±0.97**17.26±0.68***\0.0010.0120.084S C r (l m o l /L )84.86±3.50***84.22±3.5282.50±3.8988.92±1.99103.13±2.27???88.00±2.80***76.66±5.10***76.61±3.83***0.6890.001\0.001B U N (m m o l /L )15.73±0.46**15.51±0.5515.77±0.3015.91±0.4617.78±0.32??15.24±0.43***14.39±0.86**15.09±0.77**0.7960.0190.017V a r i a b l e N o n -O XO X2-w a y A N O V A (P v a l u e )A l l o p u r i n o lA l l o p u r i n o lV e h i c l e 5(m g /k g )V e h i c l e5(m g /k g )O XA PO X 9A PS U A (l m o l /L )292.29±4.03***228.16±8.74???414.04±12.57???253.33±11.83***\0.001\0.001\0.001V U r i n e i n 24h (l L )519.38±62.54465.00±41.90596.88±95.06510.00±60.000.3730.3050.812U U A i n 24h (m g )0.58±0.03**0.53±0.040.36±0.05??0.55±0.06*0.0480.1330.015U C r i n 24h (m g )0.58±0.06**0.54±0.040.33±0.04??0.58±0.04***0.0490.0470.005F E U A 18.06±1.44**17.79±0.1411.57±0.52??17.49±0.29***0.0020.0070.003S C r (l m o l /L )84.86±3.50***84.22±3.52103.13±2.27???88.92±1.99***0.121\0.001\0.001B U N (m m o l /L )15.73±0.46**16.24±0.3517.78±0.32??15.67±0.18***0.0410.0280.001V a l u e s r e p r e s e n t e d t h e m e a n ±S E M (n =8).??P \0.01,???P \0.001v e r s u s n o r m a l v e h i c l e g r o u p (N o n -O X ).*P \0.05,**P \0.01,***P \0.001v e r s u s h y p e r u r i c e m i a v e h i c l e g r o u p (O X )Eur J Nutr (2012)51:593–60659712325mg/kg)exhibited dose-dependent manners.2-way ANOVA revealed significant effects of quercetin factor and oxonate9quercetin interaction on excretion of uric acid and creatinine,serum creatinine and BUN levels,as well as of oxonate factor and quercetin factor on FEUA in quer-cetin-treated mice(Table2).Allopurinol at5mg/kg attenuated oxonate-induced alterations of uric acid (P\0.05)and creatinine(P\0.001)excretion,serum creatinine(P\0.01)and BUN(P\0.001)levels,and FEUA(P\0.001)in mice(Table2).2-way ANOVA revealed significant effects of oxonate factor,allopurinol factor and oxonate9allopurinol interaction on creatinine excretion,FEUA and BUN levels,and of oxonate factor and oxonate9allopurinol on uric acid excretion,while 2-way ANOVA showed significant effects of allopurinol factor and oxonate9allopurinol interaction on serum creatinine levels(Table2).In addition,quercetin and allopurinol did not produce any alternations in normal mice.Expressions of renal organic anion transportersTo determine whether the enhancement of renal urate excretion was due to regulate renal organic anion transport-ers,the expression levels of renal mOAT1,mOAT3, mURAT1and mGLUT9were examined,respectively.The decreased renal mOAT1mRNA levels(P\0.01)and increased renal mURAT1(P\0.001)and mGLUT9 (P\0.001)mRNA levels were observed in hyperuricemic mice compared to normal vehicle group(Fig.1a).Quercetin at50and100mg/kg effectively up-regulated mOAT1 (P\0.001,P\0.01)and down-regulated mGLUT9 (P\0.001,P\0.001)at mRNA levels in hyperuricemic mice compared to hyperuricemia vehicle group(Fig.1a). Quercetin also decreased renal mURAT1mRNA levels of hyperuricemic mice at the tested doses(P\0.05,P\0.001, P\0.001)(Fig.1a).Allopurinol at5mg/kg completely reduced mURAT1(P\0.001)and increased mOAT1 (P\0.05)mRNA levels but failed to significantly affect mGLUT9mRNA levels in this model(Fig.1a).Furthermore, renal mOAT1protein levels(P\0.001)was decreased in hyperuricemic mice,which were attenuated by quercetin significantly(P\0.01,P\0.001,P\0.001)(Fig.1b). The protein levels of renal mURAT1(P\0.001)and mGLUT9(P\0.01)were significantly increased in hyper-uricemic mice compared to normal vehicle animals(Fig.1b). Administration of50and100mg/kg quercetin to hyperuri-cemic mice resulted in recovery of mURAT1(P\0.05, P\0.01)and mGLUT9(P\0.01,P\0.001)at protein levels compared to hyperuricemia vehicle group(Fig.1b). Allopurinol at5mg/kg could reverse oxonate-induced alterations of renal mURAT1(P\0.05)and mOAT1 (P\0.001)protein levels,but fail to significantly affect renal mGLUT9protein levels(Fig.1b).In addition,there was no remarkable difference in renal mOAT3expression between the tested groups(data not shown).Quercetin and allopurinol did not produce expression changes of these renal organic anion transporters in normal groups.Expressions of renal organic cation and carnitine transportersTo explore the protective mechanisms of quercetin against renal dysfunction in oxonate-induced hyperuricemic mice,the expression changes for renal organic cation/carnitine trans-porters mOCT1,mOCT2,mOCTN1and mOCTN2were also examined.In comparison to normal vehicle mice,oxonate significantly caused down-regulation of renal mOCT1, mOCT2,mOCTN1and mOCTN2at mRNA levels (P\0.001,P\0.001,P\0.001,P\0.001)in mice (Fig.2a).Quercetin at25,50and100mg/kg effectively up-regulated renal mOCT1(P\0.05,P\0.05,P\0.001)and mOCT2(P\0.001,P\0.001,P\0.001)mRNA levels compared to hyperuricemia vehicle group(Fig.2a).50and 100mg/kg quercetin could significantly up-regulate mOC-TN1(P\0.05,P\0.01)and mOCTN2(P\0.01, P\0.001)mRNA levels in hyperuricemic mice(Fig.2a). Allopurinol at5mg/kg remarkably elevated renal mOCT1 (P\0.001),mOCT2(P\0.001),mOCTN1(P\0.01)and mOCTN2(P\0.01)mRNA levels in hyperuricemic mice (Fig.2a).The reduced protein levels of renal mOCT1, mOCT2,mOCTN1and mOCTN2(P\0.001,P\0.001, P\0.001,P\0.001)were observed in hyperuricemic mice, which were attenuated by50and100mg/kg quercetin (mOCT1:P\0.01,P\0.001;mOCT2:P\0.01, P\0.01;mOCTN1:P\0.01,P\0.001;mOCTN2: P\0.01,P\0.001)compared to hyperuricemia vehicle group(Fig.2b).Additionally,25mg/kg quercetin could up-regulate renal mOCT1,mOCTN1and mOCTN2protein lev-els(P\0.05,P\0.05,P\0.05).Allopurinol at5mg/kg also significantly increased renal mOCT1,mOCT2,mOCTN1 and mOCTN2protein levels(P\0.001,P\0.01, P\0.001,P\0.001)in this model(Fig.2b).In addition, there was no significant alteration in renal organic cation/ carnitine transporters of normal mice treated with quercetin and allopurinol.UMOD level and mRNA expressionIn order to confirm the role of UMOD in oxonate-induced hyperuricemia and renal dysfunction in mice,UMOD concentrations in serum,urine and kidney,as well as renal UMOD mRNA expression were determined.Hyperurice-mic mice showed that UMOD concentrations were signif-icantly reduced in urine(P\0.01)(Table3),but increased in serum(P\0.01)and kidney(P\0.001)598Eur J Nutr(2012)51:593–606 123(Table 3)compared to normal vehicle animals.Quercetin at 25,50and 100mg/kg effectively reversed oxonate-induced alternations of UMOD concentrations in serum (P \0.001,P \0.001,P \0.01)and kidney (P \0.05,P \0.01,P \0.01)in mice compared to hyperuricemia vehicle group (Table 3).Quercetin at two high dosesVehicle Vehicle 25 50 100 5(mg/kg)Vehicle25 50 1005(mg/kg)580 bp 342316mGAPDH299 bpNon-OX 2.02.0Non-OX Vehicle Vehicle 25 50 100 5Vehicle25 50 100 5(mg/kg)OXNon-OX 2.0e )2.0OXNon-OX s Eur J Nutr (2012)51:593–606599123lowered urinary UMOD levels (P \0.001,P \0.01)(Table 3)in hyperuricemic mice.Moreover,2-way ANOVA displayed significant effects of oxonate and quercetin on urinary UMOD concentrations,quercetin and oxonate 9quercetin interaction on serum UMOD con-centrations,and oxonate,quercetin and their interaction on renal UMOD concentrations.Allopurinol at 5mg/kg suc-ceeded in decreasing UMOD concentrations in urine (P \0.001),serum (P \0.01)and kidney (P \0.05)in hyperuricemic mice,exhibiting oxonate 9allopurinol interaction.Meanwhile,up-regulation of renal UMOD mRNA levels was observed in this model (P \0.01)(Fig.3).Administration of 50and 100mg/kg quercetin tohyperuricemic mice resulted in recovery of renal UMOD mRNA expression (P \0.05,P \0.01)(Fig.3).Allopu-rinol at 5mg/kg also reduced renal UMOD mRNA levels in hyperuricemic animals (P \0.05).Quercetin and allo-purinol had no significant effects on UMOD level and expression of normal animals.DiscussionThe present study confirmed that quercetin promoted renal excretion of uric acid with the uricosuric effect and kidney function improvement.It was noted that quercetin showedVehicle25 50 100 5315 bp 331 bp mOCTN1392 bp mOCTN2623 bp mGAPDH299 bp2.0OXNon-OX 2.0OXNon-OX 600Eur J Nutr (2012)51:593–606123。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

A PPLIED AND E NVIRONMENTAL M ICROBIOLOGY,Feb.2003,p.1013–1022Vol.69,No.2 0099-2240/03/$08.00ϩ0DOI:10.1128/AEM.69.2.1013–1022.2003Copyright©2003,American Society for Microbiology.All Rights Reserved.Three Transporters Mediate Uptake of Glycine Betaine and Carnitine by Listeria monocytogenes in Response to Hyperosmotic StressApostolos S.Angelidis and Gary M.Smith*Department of Food Science and Technology,University of California,Davis,California95616Received3September2002/Accepted18November2002The uptake and accumulation of the potent osmolytes glycine betaine and carnitine enable the food-bornepathogen Listeria monocytogenes to proliferate in environments of elevated osmotic stress,often renderingsalt-based food preservation inadequate.To date,three osmolyte transport systems are known to operate in L.monocytogenes:glycine betaine porter I(BetL),glycine betaine porter II(Gbu),and a carnitine transporterOpuC.We investigated the specificity of each transporter towards each osmolyte by creating mutant derivativesof L.monocytogenes10403S that possess each of the transporters in isolation.Kinetic and steady-state osmolyteaccumulation data together with growth rate experiments demonstrated that osmotically activated glycinebetaine transport is readily and effectively mediated by Gbu and BetL and to a lesser extent by OpuC.Osmotically stimulated carnitine transport was demonstrated for OpuC and Gbu regardless of the nature ofstressing salt.BetL can mediate weak carnitine uptake in response to NaCl stress but not KCl stress.No othertransporter in L.monocytogenes10403S appears to be involved in osmotically stimulated transport of eitherosmolyte,since a triple mutant strain yielded neither transport nor accumulation of glycine betaine orcarnitine and could not be rescued by either osmolyte when grown under elevated osmotic stress.Listeriosis is a food-borne disease that mainly affects immu-nocompromised individuals and is approximately25%fatal. The causative agent,Listeria monocytogenes,is a ubiquitous gram-positive organism that is often isolated from foods of plant or animal origin(21).The infectious dose for humans remains unknown and most likely varies depending on the immune status of the individual.Controlling the proliferation of L.monocytogenes in foods is often problematic,because the pathogen is markedly resistant to classical methods of food preservation such as acidification(grows at pH as low as4.5 [4]),increased osmotic pressure(NaCl concentrations as high as10%),and cold storage(temperatures as low asϪ0.5°C)(5). Central to the pathogen’s capacity to withstand and prolif-erate in environments of increased osmotic strength is its abil-ity to accumulate compatible solutes pati-ble solutes,sometimes called osmolytes,are low-molecular-weight,highly soluble compounds that bear no net charge at physiological pH and function as osmoprotectants in a variety of eukaryotic and prokaryotic organisms(31).The molecular basis of their action,although not completely understood,en-tails their accumulation to high levels inside the cell in re-sponse to increased external osmolarity,thus restoring turgor, without affecting cytoplasmic functions(31).Glycine betaine, carnitine,acetylcarnitine,␥-butyrobetaine,proline betaine, and3-dimethylsulphoniopropionate have been shown to con-fer osmoprotection in L.monocytogenes in synthetic media(3). Neither glycine betaine nor carnitine can be synthesized by L. monocytogenes,and their accumulation is achieved by active transport from the environment.Two transport systems have been biochemically and genetically identified as glycine betaine transporters(9,10,13,22),and one has been identified as a carnitine transporter(1,7,24,29).Glycine betaine porter II(Gbu)is an ATP binding cassette (ABC)transporter that is encoded by the gbu operon(13). Gbu,which mediates the uptake of glycine betaine,can be activated by increased osmotic pressure or decreased temper-ature(9,13).Glycine betaine porter I(BetL)is a secondary transporter that is activated by an increase in medium osmo-larity and mediates the cotransport of glycine betaine with a sodium ion(a glycine betaine-Naϩsymporter)(10,22).OpuC, the product of the opuC operon,is an ABC transporter that has been shown to transport carnitine in response to osmotic and cold stress(1,7,24).The transport characteristics of Gbu,BetL,and OpuC have been studied by the isolation of strains with single mutations in genes encoding transport systems and comparing their ability to transport glycine betaine or carnitine to that of their respec-tive wild-type isogens.Although this approach proved useful in isolating and identifying the three transporters,substrate spec-ificity remains uncertain.Furthermore,whether additional gly-cine betaine and carnitine transporters operate in L.monocy-togenes remains unknown.Therefore,the objectives of this work were to examine the transporters’specificities for glycine betaine and carnitine in detail,to investigate whether addi-tional transporters for either osmolyte operate in L.monocy-togenes under osmotic stress,and to compare the osmoprotec-tive potentials of these transporters in environments where glycine betaine,carnitine,or both are present.In order to achieve these objectives,double and triple transporter mutants were constructed and characterized so that Gbu,BetL,and OpuC could be studied without mutual interference.A sub-stantially similar study has appeared previously(30)but em-ployed a different strain of L.monocytogenes and slightly dif-ferent techniques,yielding different results.*Corresponding author.Mailing address:Department of Food Science and Technology,University of California,Davis,CA95616. Phone:(530)752-6168.Fax:(530)752-4759.E-mail:gmsmith@.1013MATERIALS AND METHODSBacterial strains,media,and chemicals.L.monocytogenes10403S was the wild-type strain used in this work(28).Cultures were kept on brain heart infusion (BHI)(Difco)agar plates at4°C.Modified(lacking choline)Pine’s medium(19) containing0.5%glucose was used as the defined medium.Escherichia coli DH5␣was maintained on Luria-Bertani agar(20).Glycine betaine,carnitine,NaCl,and KCl were purchased from Sigma Chemical Co.(St.Louis,Mo.).[methyl-14C]car-nitine,and[methyl-14C]choline were purchased from Perkin-Elmer Life Sci-ences,Inc.(Boston,Mass.).[methyl-14C]glycine betaine was prepared by oxida-tion of[methyl-14C]choline(18).Ampicillin(50␮g/ml)and chloramphenicol (CHL)(10␮g/ml)were purchased from Sigma and used as appropriate.Stan-dard methods were used for routine DNA manipulations(20).DNA polymerase was purchased from Eppendorf Scientific Inc.(Westbury,N.Y.),nucleotides and DNA-modifying enzymes were from Roche Molecular Biochemicals(Indianap-olis,Ind.),and DNA purification was performed with cartridges from Qiagen Inc. (Valencia,Calif.).Construction of L.monocytogenes transporter mutant strains.(i)Construction of single mutants.The splicing by overlap extension(SOE)PCR approach(11) was used to create internal deletion constructs for gbu,betL,and opuC.For the gbu operon,twoϳ400-bp fragments were amplified:one in the5Јregion of the operon,inside the gbuA gene(nucleotides612to1012of the operon)was amplified using primers gSOE-A and gSOE-B(Table1).The second fragment was at the3Јregion of the operon,inside the gbuC gene(nucleotides2849to 3213),amplified using primers gSOE-C and gSOE-D.Following purification,the two PCR products were used as templates in a third PCR with primers gSOE-A and gSOE-D,which generated a766-bp gbu hybrid product bearing a1,836-bp deletion.Purified product was digested with Eco RI and Xba I,cloned into the E. coli-L.monocytogenes shuttle vector pKSV7(25),and transformed into E.coli DH5␣to yield plasmid pMIA.pMIA was electroporated(17)into L.monocy-togenes10403S,and transformants were selected on BHI plates containing CHL (10␮g/ml).Several colonies were picked from the transformation plates and individually propagated at40°C(a nonpermissive temperature for pKSV7rep-lication)in BHI broth containing CHL(10␮g/ml)for approximately30gener-ations,and colonies with chromosomally integrated plasmid were isolated in BHI-CHL plates at40°C.A single colony from the BHI-CHL plates was picked up and propagated for approximately50generations in BHI broth at30°C to select for excision of the plasmid from the chromosome.Curing of the excised plasmid was achieved by sequential passage of the culture(approximately30 generations)in BHI broth at40°C,after which the culture was colony purified on BHI plates.Five hundred colonies were screened for loss of CHL resistance by replica plating(patching)on BHI-CHL and BHI plates,and among those show-ing CHL sensitivity,those having a mutant allele in the chromosome were identified using PCR(primers gSOE-F and gSOE-R).One of these mutants,L. monocytogenes ASA1(SOE gbu10),was used for further genetic manipulations (construction of double mutants).Similarly,for the opuC operon,two fragments were amplified:one in the5Јregion of the operon,inside the opuCA gene(nucleotides200to652of the operon)was amplified using primers oSOE-A and oSOE-B(Table1).The second fragment was at the3Јregion of the operon,inside the opuCD gene (nucleotides3170to3598),amplified using primers oSOE-C and oSOE-D.Fol-lowing purification,the two PCR products were used as templates in a third PCR with primers oSOE-A and oSOE-D,which generated an882-bp opuC hybrid product bearing an internal2,517-bp deletion.Purified product was digested with Hin dIII and Bam HI,cloned into vector pKSV7and transformed into E.coli DH5␣to yield plasmid pZWH.pZWH was electroporated into L.monocytogenes 10403S,and transformants were selected on BHI-CHL plates.The remaining integration,excision,and curing steps as well as the screening for opuC deletion mutants were analogous to those used to construct mutant SOE gbu10.CHL-sensitive mutants were examined for chromosomal deletion using PCR(primers oSOE-F and oSOE-R).The resulting mutant with an in-frame deletion in the opuC operon(SOE opuC15)was designated ASA2.For creation of a betL mutant,the SOE(bSOE-A,bSOE-B,bSOE-C,and bSOE-D)and forward and reverse(bSOE-F and bSOE-R)primers used were of the same sequence as those used by Sleator et al.(23).The hybrid600-bp betL construct(comprised of two regions in the5Јand3Јend of betL)was digested with Xba I and Hin dIII,cloned into pKSV7,and transformed into E.coli DH5␣to yield plasmid pAEK.pAEK was similarly electroporated into L.monocyto-genes10403S.The remaining steps were identical to those described above forTABLE1.PCR primers used in this studyPrimer Sequence(5Ј33Ј)gSOE-A a...............................................................................................CGT CGA ATT CAG CCT ACG AGCgSOE-B.................................................................................................TCG AGC AAT TGA TCT TGC ATgSOE-C b...............................................................................................ATG CAA GAT CAA TTG CTC GAC CTT CCG CGT ACC AAG TGT TAG gSOE-D a...............................................................................................TAA ATT CTA GAA GTA TTT GGA AGCgSOE-F.................................................................................................CTT TGG TTT ATT CCC GAA CAG AACgSOE-R.................................................................................................TTT GTC ATG TAT TTT GGT ACT GCoSOE-A a...............................................................................................GTA ACG AAG CTT TAT AAA GGG GoSOE-B.................................................................................................AAT CAA GTT TTG CTC TGCoSOE-C b...............................................................................................GCA GAG CAA AAC TTG ATT CAA ACA ATT CCG GCA CTA GCA ATG T oSOE-D a...............................................................................................GCG TTG GAT CCA ACC AAG AAG ToSOE-F.................................................................................................TGG ACA GCA GCA ACG TAT AGoSOE-R................................................................................................CAT TTA TGA TAA AAA GTT TAC TACbSOE-A a...............................................................................................TTT CTA GAA AGT AAT TTT GGT TGG TATbSOE-B.................................................................................................TCC CCA GTG GAA GAA TGAbSOE-C b...............................................................................................TCA TTC TTC CAC TGG GGA ATT TTT GTC GAA CAA CAT GGT AAT bSOE-D a...............................................................................................AAT CGA AGC TTT TTG AAG CGC TGTbSOE-F.................................................................................................AGT CCG ATT GGC TCG ATT CGA CbSOE-R.................................................................................................TCG CGA AAT AGT CGC GGC AAA GCa Nucleotide substitutions to create restriction sites are underlined.b Overhangs complementary to SOE-B primers are underlined.TABLE2.Bacterial strains and plasmids used in this studyStrain or plasmid Relevant property or genotype Source orreferenceStrainsE.coli DH5␣L.monocytogenes10403S Wild type28ASA1⌬gbu10This studyASA2⌬opuC15This studyASA3⌬betL25This studyASA4⌬gbu10⌬betL25This studyASA5⌬opuC15⌬betL25This studyASA6⌬gbu10⌬opuC15This studyASA7⌬gbu10⌬opuC15⌬betL25This studyPlasmidspKSV725pMIA pKSV7carrying spliced DNA from gbu This studypZWH pKSV7carrying spliced DNA from opuC This studypAEK pKSV7carrying spliced DNA from betL This study 1014ANGELIDIS AND SMITH A PPL.E NVIRON.M ICROBIOL.isolation of the other single mutants.The resulting L.monocytogenes betL mutant (SOE betL25)with an internal 681-bp deletion was designated ASA3.(ii)Construction of double mutants and triple mutant.Double transporter mutant strains (SOE gbu10-betL25and SOE opuC15-betL25)were constructed by electroporating the pKSV7plasmid derivatives pMIA and pZWH,respectively,into L.monocytogenes ASA3(the betL deletion mutant SOE betL25),and this was followed by the integration,excision,curing and,screening steps described above.These strains were designated ASA4and ASA5,respectively.Finally,constructions of the third double mutant,ASA6(SOE gbu10-opuC15),and the triple transporter mutant,ASA7(SOE gbu10-opuC15-betL25),were initiated by electroporating pMIA into ASA2and ASA5,respectively.Allelic exchange events were con firmed by PCR ampli fication using the SOE-F and SOE-R primer sets.Measurement of generation time under osmotic stress in the presence and absence of osmolytes.To inoculate Pine ’s medium for growth rate determination,L.monocytogenes cultures were grown overnight at 30°C in BHI broth,and 1-ml aliquots were centrifuged at 11,750ϫg for 10min.The pellets were washed twice with 1-ml portions of Pine ’s medium and used to inoculate (0.5%)125-ml Pyrex nephelo flasks containing Pine ’s medium.These flask cultures were grown at 30°C to cell densities of ca.2ϫ109CFU/ml,diluted 10-fold in Pine ’s medium,and used to inoculate (1%)eight sets of 125-ml Pyrex nephelo flasks containing 15ml of Pine ’s medium.These sets were incubated with mild shaking (40rpm)at 30°C.Cultures were stressed with either 0.7M NaCl or an isosmotic equivalent of KCl (0.72M)and incubated in the absence of osmolytes or in the presence of 1mM glycine betaine,1mM carnitine,or both osmolytes at a concentration of 0.5mM each.Unstressed cultures with and without osmolytes were used as controls.Growth was monitored with a Klett-Summerson photoelectric colorim-eter with a green (no.54)filter.Each combination of strain,salt stress,and osmolyte was tested in triplicate.Speci fic growth rate constants (␬)were calcu-lated by plotting the natural logarithm of the number of Klett units versus time and converted to their respective generation time values (g ).Transport and steady-state cytoplasmic levels of glycine betaine and carnitine.Transport of glycine betaine and carnitine was examined for the wild-type L.monocytogenes 10403S,all three double mutant strains (ASA4,ASA5,and ASA6),and the triple mutant strain,ASA7.Transport of these osmolytes was examined at 30°C under osmotic stress provided by 0.7M NaCl or 0.72M KCl and under baseline conditions (no salt added).For each combination of strain and osmotic stress,transport assays were done in duplicate using 100␮M [meth-yl -14C]glycine betaine and [methyl -14C]carnitine as described previously (14).Uptake rates were normalized to total cellular protein,which was determined using the bicinchoninic acid method (27)(Pierce Chemical,Rockford,Ill.)and are reported as nanomoles of osmolyte per minute per milligram of cellular protein.L.monocytogenes 10403S,ASA4,ASA5ASA6,and ASA7were grown aero-bically in modi fied Pine ’s medium containing 0.5mM (each)glycine betaine and carnitine and 0.7M NaCl.Unstressed cultures grown at 30°C with added os-molytes served as controls.Cultures were harvested at late log phase by centrif-ugation (4,080ϫg for 10min at 4°C).The pelleted cells were immediately washed with ice-cold 0.775M NaCl solution.Cytoplasmic contents were ex-tracted with ice-cold 7%perchloric acid as described elsewhere (26).Extracts were analyzed by natural-abundance 13C nuclear magnetic resonance (13C-NMR)as previously described (1).Total cellular protein at the time of harvest was used to normalize compatible solute concentrations.RESULTSSingle,double,and triple transporter mutant construction.Allelic exchange mutagenesis was used to create deletions in the gbu and opuC operons and the betL gene,which encode the ATP-driven glycine betaine transporter Gbu,the ATP-driven carnitine transporter OpuC,and the Na ϩ-glycine betaine sym-porter BetL,respectively.In each case,DNA fragments near the 5Јand 3Јends were independently ampli fied,spliced,and cloned into the E.coli -L.monocytogenes shuttle vector pKSV7to generate the recombinant-pKSV7vector derivatives pMIA,pZWH,and pAEK that carry the spliced regions of the gbu and opuC operons and betL gene,respectively.Each recombinant pKSV7derivative was independently electroporated into the wild-type L.monocytogenes 10403S.Chromosomal integration of plasmid vectors was selected for by growth of transformed L.monocytogenes cells for several generations in BHI broth at 40°C in the presence of CHL (10␮g/ml).Excision ofchromo-FIG.1.DNA sizes after PCR ampli fication of chromosomal DNA extracted from wild-type L.monocytogenes 10403S ;the double-mutant derivatives ASA4(⌬betS ⌬gbu ),ASA5(⌬betL ⌬opuC ),and ASA6(⌬gbu ⌬opuC );and the triple mutant ASA7(⌬betL ⌬gbu ⌬opuC )with the gene speci fic SOE-F and SOE-R nes 1,PCR with betL primers;lanes 2,PCR with opuC primers;lanes 3,PCR with gbu primers.DNA ladder positions (in base pairs)from bottom to top:200,400,600,800,1,000,1,500,2,000,2,500,3,000,4,000,5,000,6,000,8,000,and 10,000.TABLE 3.Expected DNA size after PCR ampli fication of wild-type and mutant chromosomal DNA with primers SOE-F and SOE-R aL.monocytogenes geneSize (bp)in:10403SSOE mutantgbu 2,575738opuC 3,149631betL1,411730agSOE-F and gSOE-R for gbu ,oSOE-F and oSOE-R for opuC ,and bSOE-F and bSOE-R for betL .V OL .69,2003OSMOLYTE TRANSPORT IN L.MONOCYTOGENES 1015somally integrated plasmids was facilitated by repeated grow-ing of cells in BHI at 30°C in the absence of antibiotic pressure,and curing of excised plasmids was carried out by subsequent shift of the growth temperature at 40°C for several generations,after which bacteria were colony isolated on BHI plates and individual colonies were screened for loss of CHL resistance.Several CHL-sensitive colonies were screened by PCR to find bacteria in which the allelic exchange event resulted in a mu-tant phenotype (chromosomal replacement of wild-type copy of the gene with the mutant allele).This first round of allelic exchange mutagenesis resulted in three mutant derivatives:L.monocytogenes ASA1,a mutant with a 1,836-bp deletion in the gbu operon (from nucleotide 1013in gbuA to nucleotide 2848in gbuC );L.monocytogenes ASA2,a mutant with a2,518-bpFIG.2.Osmolyte transport activity of L.monocytogenes 10403S and mutant derivatives ASA4,ASA5,ASA6,and ASA7.Uptake of 100␮M [14C]glycine betaine (A,C,E,G,and I)or carnitine (B,D,F,H,and J)was measured in strain 10403S (A and B),ASA5(C and D),ASA4(E and F),ASA6(G and H),and ASA7(I and J)grown to late log phase in modi fied Pine ’s medium at 30°C with 0.7M NaCl (triangles),0.72M KCl (squares),or no added salt (circles).Transport was assayed as described in Materials and Methods.Error bars indicate the range of duplicate values.Note that the scales on the time axes vary.1016ANGELIDIS AND SMITH A PPL .E NVIRON .M ICROBIOL .deletion in the opuC operon (from nucleotide 653in opuCA to nucleotide 3169in opuCD );and L.monocytogenes ASA3,a mutant with a 681-bp deletion in the betL gene (from nucleo-tide 623to 1303).L.monocytogenes single transporter mutant strains ASA2and ASA3were used as starting strains for a second round of two-step allele replacement mutagenesis which began with the transformation of ASA3with the recombinant vectors pMIA or pZWH and with the transformation of ASA2with pMIA.The three resulting double-mutant strains were ASA4,a strain with deletions in the gbu operon and betL gene;ASA5,a double betL and opuC mutant;and ASA6,a double mutant in gbu and opuC (Table 2).Construction of a mutant in all three genes (ASA7)was initiated by transforming pMIA into ASA5and proceeding in the same manner as described above.Figure 1shows the sizes of DNA fragments resulting from ampli fica-tion of chromosomal DNA (extracted from the wild-type L.monocytogenes 10403S,the three double mutants and the triple mutant)with the three SOE-F and SOE-R gene-speci fic primer sets.Table 3presents the expected wild-type and mu-tant DNA sizes after PCR ampli fication of chromosomal DNA by the respective pair of SOE-F and SOE-R primer for each gene.Uptake of glycine betaine and carnitine by L.monocytogenes under osmotic stress.L.monocytogenes 10403S,ASA4,ASA5,ASA6,and ASA7were grown at 30°C in modi fied Pine ’s me-dium in the presence of 0.7M NaCl or 0.72M KCl or without added salt.Exponentially growing cultures were centrifuged and resuspended in buffer of the same osmolality as that of the growth medium,and uptake of glycine betaine or carnitine was measured over time after addition of [methyl -14C]glycine be-taine or [methyl -14C]carnitine to the cultures (Fig.2).Transport of glycine betaine.Glycine betaine transport in L.monocytogenes is osmotically activated (14)(Fig.2A).Under osmotic stress,the rate of transport through the ABC trans-porter Gbu (Fig.2C)was orders of magnitude higher than that of the secondary Na ϩsymporter BetL (Fig.2G).BetL ef fi-ciently transported glycine betaine only under NaCl-mediated stress.The nonzero rate of transport under KCl-mediated stress was equal to the baseline level of transport (observed in unstressed cells)and was probably due to the baseline osmo-lality of the assay buffer and the presence of sodium ion from the growth medium and assay buffer (Fig.2G).Weak glycine betaine transport from OpuC was observed under both stresses (Fig.2E).Transport of carnitine.Carnitine transport in L.monocyto-genes is also osmotically regulated (Fig.2B).Our results show that Gbu (Fig.2D)and OpuC (Fig.2F)can readilymediateFIG.2—Continued .V OL .69,2003OSMOLYTE TRANSPORT IN L.MONOCYTOGENES 1017carnitine uptake in response to osmotic stress.Weak,transient carnitine uptake was also observed by BetL when Naϩwas present in the assay medium(Fig.2H).As expected,the stron-gest carnitine uptake was observed by the dedicated carnitine transporter OpuC(Fig.2F).No uptake of either osmolyte was observed by the triple mutant L.monocytogenes ASA7,even under conditions of os-motic activation(Fig.2I and J).Compatible solute accumulation under osmotic stress.L. monocytogenes strains(10403S,ASA4,ASA5,ASA6,and ASA7)were grown in defined medium at30°C with a0.5mM concentration(each)of glycine betaine and carnitine,and with or without0.7M NaCl.13C-NMR analysis was performed on perchloric acid extracts of cells from cultures in balanced growth.With the exception of low levels of glutamate,no other osmolyte was detected in cell extracts of any strain in the absence of stress(data not shown).When grown under osmotic stress(0.7M NaCl),wild-type L.monocytogenes accumulated glycine betaine,carnitine,and glutamate(Fig.3).Cell extracts of mutant ASA5,which only possesses the Gbu transporter,had increased levels of glycine betaine and glutamate,but carnitine accumulation was not detected.Extracts of ASA4(only OpuC transporter present) contained increased levels of carnitine and glutamate but no detectable glycine betaine.Extracts of mutant ASA6(only BetL porter present)contained increased levels of glutamate and a level of glycine betaine that was comparable to,albeit somewhat lower than,that of the wild type and contained no detectable carnitine.Glutamate was the sole detectable os-molyte in extracts of the triple mutant ASA7.However gluta-mate accumulation by ASA7was the highest among those measured in extracts of all other(wild-type or double-mutant) strains.It is therefore evident that,when transport of glycine betaine or carnitine is impaired,osmotically stressed L.mono-cytogenes increases the accumulation of glutamate and that of the other potent osmolyte(carnitine or glycine betaine).We have also observed this phenomenon in chilled,stressed cells (2).When osmotically stressed L.monocytogenes is impaired in transport of both glycine betaine and carnitine,as is the case with the triple mutant ASA7,glutamate was the only solute that accumulated appreciably.Whether the accumulation of glutamate is the result of active transport,increased biosyn-thesis,or reduced turnover remains unknown.Growth under osmotic stress in the presence or absence of glycine betaine and carnitine.The effectiveness of each trans-port system in alleviating osmotic stress in media with different compatible solute composition was determined by measuring the growth of thefive strains in Pine’s medium with0.7M NaCl (Fig.4A),with0.72M KCl(Fig.4B),or without added salt (data not shown),in the absence or presence of1mM glycine betaine or carnitine or a0.5mM concentration of each os-molyte combined.Regardless of the osmolyte present,un-stressed cultures grew with a generation time(meanϮstan-dard deviation)of1.33Ϯ0.09h,and no significant differences in growth were observed among stressed cultures in the ab-sence of osmolytes(Fig.4).The following comparisons can be made in the growth of the five strains under osmotic stress conferred by0.7M NaCl. Compared to the growth rates observed in the absence of osmolytes,wild-type L.monocytogenes grew twice as fast in the presence of either osmolyte in the growth medium,with gly-cine betaine being slightly more osmoprotective than carnitine. Mutant ASA5,which possesses only the Gbu porter,also showed a50%reduction in the generation time when glycine betaine was present;the presence of carnitine did confer some osmoprotection(24%reduction in generation time),but dis-tinctly less than that offered by glycine betaine.An analogous response was exhibited by strain ASA4,which possesses only the carnitine transporter OpuC.Carnitine was very effective (generation time reduced by55%),whereas glycine betaine was less effective(30%reduction).For strain ASA6,which only carries the glycine betaine symporter BetL,glycine be-taine provided an osmoremedial effect that was equal in mag-nitude to that in strain ASA5,whereas the inclusion of carni-tine did not result in any reduction in generation time. Although carnitine transport was observed by BetL in the presence of sodium(Fig.2H),the transport was weak,reaching approximately100nmol of carnitine/mg of cell protein after 1h;this level of intracellular carnitine may be insufficient to alleviate osmotic stress.Finally,the growth rate of the triple mutant ASA7could not be enhanced by either osmolyte,as the resulting growth rates were indistinguishable from those of cultures without added osmolytes.The stress alleviation by osmolytes in Pine’s medium with 0.72M KCl for each of thefive strains was parallel to that described above for NaCl.The only noticeable difference was the somewhat-weaker alleviating effect of glycine betaine in strain ASA6,a result that can be explained by the need of the symporter for sodium ions for efficient glycine betaine uptake.DISCUSSIONA key feature enabling L.monocytogenes to tolerate envi-ronments of elevated osmotic stress is the pathogen’s ability to accumulate the compatible solutes glycine betaine and carni-tine from its environment.Recent work has led to the bio-chemical and genetic identification of three transport systems. BetL(10)wasfirst identified biochemically in membrane ves-icles as a glycine betaine-Naϩsymporter that responds to hy-perosmotic gradients having a strict transport requirement for sodium ion and was later identified at the genetic level as a secondary transport system that was designated BetL(22). Gbu(9),the product of the gbu operon(13),was identified as an osmotically activated and cold-activated glycine betaine ABC transporter.OpuC,an ABC transporter,has been iden-tified in four L.monocytogenes strains by three laboratories as an osmotically regulated(1,7,24)and cold-activated(1)car-nitine transporter.Given the number,complexity,and varying range of sub-strate specificity exhibited by the compatible solute transport-ers in Bacillus subtilis(12)and the lack of such detailed knowl-edge in L.monocytogenes we sought to study the three currently known compatible solute transporters in L.monocy-togenes in terms of their substrate specificity for the two most important osmolytes,glycine betaine and carnitine,and deter-mine whether the transport of either or both osmolytes is mediated through yet another unknown system.Glycine betaine transport in L.monocytogenes in response to osmotic stress.Sleator et al.(22)compared glycine betaine uptake of wild-type L.monocytogenes L028and that of L028B1018ANGELIDIS AND SMITH A PPL.E NVIRON.M ICROBIOL.。

相关文档
最新文档